Synthesis	O
and	O
characterization	O
of	O
photoreactive	O
insulin	B-Protein
-	I-Protein
like	I-Protein
growth	I-Protein
factor	I-Protein
1	E-Protein
derivatives	O
for	O
receptor	O
analysis	O
.	O

Recombinant	O
human	O
insulin	B-Protein
-	I-Protein
like	I-Protein
growth	I-Protein
factor	I-Protein
1	E-Protein
(	O
hIGF	B-Protein
-	I-Protein
1	E-Protein
)	O
was	O
reacted	O
with	O
4	O
-	O
azidosalicylic	O
acid	O
(	O
Asa	O
)	O
to	O
synthesize	O
photoreactive	O
IGF	B-Protein
-	I-Protein
1	E-Protein
derivatives	O
.	O

Depending	O
on	O
the	O
time	O
of	O
reaction	O
and	O
the	O
Asa	O
/	O
IGF	B-Protein
-	I-Protein
1	E-Protein
ratio	O
,	O
a	O
mixture	O
of	O
mono	O
-	O
,	O
bis	O
-	O
,	O
and	O
trisacylated	O
derivatives	O
and	O
one	O
tetraacylated	O
derivative	O
was	O
produced	O
,	O
which	O
was	O
separated	O
by	O
reversed	O
-	O
phase	O
HPLC	O
.	O

HPLC	O
,	O
PAGE	O
,	O
and	O
MALDI	O
mass	O
spectrometry	O
were	O
used	O
to	O
determine	O
the	O
degree	O
of	O
the	O
acylation	O
and	O
location	O
of	O
the	O
photolabel	O
insertion	O
.	O

After	O
iodination	O
of	O
the	O
three	O
monoacylated	O
photoreactive	O
IGF	B-Protein
-	I-Protein
1	E-Protein
derivatives	O
,	O
the	O
specific	O
labeling	O
of	O
the	O
receptor	O
could	O
be	O
proved	O
.	O

Together	O
with	O
a	O
comparative	O
investigation	O
in	O
which	O
B29	O
-	O
Asa	O
-	O
insulin	S-Protein
was	O
used	O
,	O
the	O
results	O
suggest	O
corresponding	O
contact	O
areas	O
for	O
IGF	B-Protein
-	I-Protein
1	E-Protein
and	O
insulin	S-Protein
with	O
the	O
insulin	B-Protein
receptor	E-Protein
ectodomain	O
.	O

Cell	O
-	O
specific	O
glycoforms	O
of	O
sialoadhesin	S-Protein
and	O
CD45	S-Protein
are	O
counter	O
-	O
receptors	O
for	O
the	O
cysteine	O
-	O
rich	O
domain	O
of	O
the	O
mannose	O
receptor	O
.	O

We	O
previously	O
reported	O
that	O
CR	O
-	O
Fc	O
,	O
an	O
Fc	O
chimeric	O
protein	O
containing	O
the	O
cysteine	O
-	O
rich	O
(	O
CR	O
)	O
domain	O
of	O
the	O
mannose	O
receptor	O
,	O
binds	O
to	O
marginal	O
zone	O
metallophilic	O
macrophages	O
(	O
Mo	O
)	O
and	O
B	O
cell	O
areas	O
in	O
the	O
spleen	O
and	O
to	O
subcapsular	O
sinus	O
Mo	O
in	O
lymph	O
nodes	O
of	O
naive	O
mice	O
(	O
CR	O
-	O
Fc	O
(	O
+	O
)	O
cells	O
)	O
.	O

Several	O
CR	O
-	O
Fc	O
ligands	O
were	O
found	O
in	O
spleen	O
and	O
lymph	O
node	O
tissue	O
lysates	O
using	O
ligand	O
blots	O
.	O

In	O
this	O
paper	O
we	O
report	O
the	O
identification	O
of	O
two	O
of	O
these	O
ligands	O
as	O
sialoadhesin	S-Protein
(	O
Sn	S-Protein
)	O
,	O
an	O
Mo	O
-	O
specific	O
membrane	O
molecule	O
,	O
and	O
the	O
leukocyte	O
common	O
antigen	O
,	O
CD45	S-Protein
.	O

CR	O
-	O
Fc	O
bound	O
selectively	O
to	O
Sn	S-Protein
purified	O
from	O
spleen	O
and	O
lymph	O
nodes	O
and	O
to	O
two	O
low	O
molecular	O
weight	O
isoforms	O
of	O
CD45	S-Protein
in	O
a	O
sugar	O
-	O
dependent	O
manner	O
.	O

CR	O
-	O
Fc	O
binding	O
and	O
non	O
-	O
binding	O
forms	O
of	O
Sn	S-Protein
,	O
probably	O
derived	O
from	O
CR	O
-	O
Fc	O
(	O
+	O
)	O
and	O
CR	O
-	O
Fc	O
(	O
-	O
)	O
cells	O
respectively	O
,	O
were	O
selected	O
from	O
spleen	O
lysates	O
.	O

Analysis	O
of	O
the	O
glycan	O
pool	O
associated	O
with	O
the	O
CR	O
-	O
Fc	O
-	O
binding	O
form	O
revealed	O
the	O
presence	O
of	O
charged	O
structures	O
resistant	O
to	O
sialidase	O
,	O
absent	O
in	O
the	O
non	O
-	O
binding	O
form	O
,	O
that	O
could	O
correspond	O
to	O
sulfated	O
structures	O
.	O

These	O
results	O
confirm	O
the	O
identification	O
of	O
the	O
CR	O
region	O
of	O
the	O
mannose	O
receptor	O
as	O
a	O
lectin	O
.	O

We	O
also	O
demonstrate	O
that	O
the	O
same	O
glycoprotein	O
expressed	O
in	O
different	O
cells	O
of	O
the	O
same	O
organ	O
can	O
display	O
distinct	O
sugar	O
epitopes	O
that	O
determine	O
its	O
binding	O
properties	O
.	O

Disrupting	O
the	O
geranylgeranylation	O
at	O
the	O
C	O
-	O
termini	O
of	O
the	O
shrimp	O
Ras	S-Protein
by	O
depriving	O
guanine	O
nucleotide	O
binding	O
at	O
the	O
N	O
-	O
terminal	O
.	O

In	O
order	O
to	O
assess	O
the	O
effects	O
of	O
guanine	O
nucleotide	O
binding	O
on	O
the	O
geranylgeranylation	O
at	O
the	O
CAAX	O
box	O
of	O
the	O
shrimp	O
Ras	S-Protein
,	O
we	O
experimented	O
with	O
the	O
shrimp	O
Penaeus	O
japonicus	O
Ras	S-Protein
(	O
S	O
-	O
Ras	S-Protein
)	O
which	O
is	O
geranylgeranylated	O
at	O
the	O
C	O
-	O
termini	O
,	O
shares	O
85	O
%	O
homology	O
with	O
mammalian	O
K	B-Protein
(	I-Protein
B	I-Protein
)	I-Protein
-	I-Protein
Ras	E-Protein
protein	O
and	O
demonstrates	O
identity	O
in	O
the	O
guanine	O
nucleotide	O
binding	O
domains	O
(	O
Huang	O
C	O
-	O
F	O
,	O
Chuang	O
N	O
-	O
N	O
.	O
1999	O
.	O
J	O
Exp	O
Zool	O
283	O
:	O
510	O
-	O
521	O
)	O
.	O

Several	O
point	O
mutations	O
in	O
the	O
S	O
-	O
ras	S-Protein
gene	O
were	O
generated	O
at	O
codons	O
12	O
(	O
G12V	O
)	O
,	O
61	O
(	O
Q61K	O
)	O
,	O
and	O
116	O
(	O
N116I	O
)	O
.	O

The	O
bacterially	O
expressed	O
mutant	O
S	O
-	O
Ras	S-Protein
proteins	O
,	O
G12V	O
and	O
Q61K	O
,	O
were	O
bound	O
with	O
GTP	O
without	O
hydrolysis	O
.	O

In	O
contrast	O
,	O
the	O
mutant	O
S	O
-	O
Ras	S-Protein
N116I	O
was	O
defective	O
in	O
its	O
ability	O
to	O
bind	O
any	O
guanine	O
nucleotides	O
.	O

Autoradiography	O
studies	O
showed	O
that	O
the	O
purified	O
shrimp	O
protein	O
geranylgeranyltransferase	B-Protein
I	E-Protein
(	O
Lin	O
R	O
-	O
S	O
,	O
Chuang	O
N	O
-	O
N	O
.	O
1998	O
.	O
J	O
Exp	O
Zool	O
281	O
:	O
565	O
-	O
573	O
)	O
was	O
unable	O
to	O
catalyze	O
the	O
transfer	O
of	O
[	O
(	O
3	O
)	O
H	O
]	O
-	O
geranylgeranylpyrophosphate	O
to	O
this	O
mutant	O
N116I	O
but	O
very	O
competently	O
caused	O
the	O
geranylgeranylation	O
of	O
GTP	O
-	O
locked	O
mutants	O
,	O
G12V	O
and	O
Q61K	O
.	O

These	O
results	O
demonstrate	O
that	O
the	O
geranylgeranylation	O
at	O
the	O
CAAX	O
box	O
of	O
the	O
shrimp	O
Ras	S-Protein
protein	O
requires	O
the	O
proper	O
binding	O
of	O
guanine	O
nucleotide	O
at	O
its	O
N	O
-	O
terminal	O
region	O
.	O

J	O
.	O

Exp	O
.	O

Zool	O
.	O

286	O
:	O
441	O
-	O
449	O
,	O
2000	O
.	O

Akr1p	S-Protein
and	O
the	O
type	O
I	O
casein	O
kinases	O
act	O
prior	O
to	O
the	O
ubiquitination	O
step	O
of	O
yeast	O
endocytosis	O
:	O
Akr1p	S-Protein
is	O
required	O
for	O
kinase	O
localization	O
to	O
the	O
plasma	O
membrane	O
.	O

Ubiquitination	O
of	O
the	O
plasma	O
membrane	O
-	O
localized	O
yeast	O
a	B-Protein
-	I-Protein
factor	I-Protein
receptor	E-Protein
(	O
Ste3p	S-Protein
)	O
triggers	O
a	O
rapid	O
,	O
ligand	O
-	O
independent	O
endocytosis	O
leading	O
to	O
its	O
vacuolar	O
degradation	O
.	O

This	O
report	O
identifies	O
two	O
mutants	O
that	O
block	O
uptake	O
by	O
blocking	O
ubiquitination	O
,	O
these	O
being	O
mutant	O
either	O
for	O
the	O
ankyrin	O
repeat	O
protein	O
Akr1p	S-Protein
or	O
for	O
the	O
redundant	O
type	O
I	O
casein	O
kinases	O
Yck1p	S-Protein
and	O
Yck2p	S-Protein
.	O

While	O
no	O
obvious	O
defect	O
was	O
seen	O
for	O
wild	O
-	O
type	O
Ste3p	S-Protein
phosphorylation	O
in	O
akr1	S-Protein
or	O
yck	O
mutant	O
backgrounds	O
,	O
examination	O
of	O
the	O
Delta320	O
-	O
413	O
Ste3p	S-Protein
deletion	O
mutant	O
phosphorylation	O
did	O
reveal	O
a	O
clear	O
defect	O
in	O
both	O
mutants	O
.	O

The	O
Delta320	O
-	O
413	O
deletion	O
removes	O
18	O
Ser	O
-	O
Thr	O
residues	O
(	O
possible	O
YCK	O
-	O
independent	O
phosphorylation	O
sites	O
)	O
yet	O
retains	O
the	O
15	O
Ser	O
-	O
Thr	O
residues	O
of	O
the	O
Ste3p	S-Protein
PEST	O
-	O
like	O
ubiquitination	O
-	O
endocytosis	O
signal	O
.	O

Two	O
other	O
phenotypes	O
link	O
akr1	S-Protein
and	O
yck	O
mutants	O
:	O
both	O
are	O
defective	O
in	O
phosphorylation	O
of	O
wild	O
-	O
type	O
alpha	B-Protein
-	I-Protein
factor	I-Protein
receptor	E-Protein
,	O
and	O
while	O
both	O
are	O
defective	O
for	O
Ste3p	S-Protein
constitutive	O
internalization	O
,	O
both	O
remain	O
partially	O
competent	O
for	O
the	O
Ste3p	S-Protein
ligand	O
-	O
dependent	O
uptake	O
mode	O
.	O

Yck1p	S-Protein
-	O
Yck2p	S-Protein
may	O
be	O
the	O
function	O
responsible	O
in	O
phosphorylation	O
of	O
the	O
PEST	O
-	O
like	O
ubiquitination	O
-	O
endocytosis	O
signal	O
.	O

Akr1p	S-Protein
appears	O
to	O
function	O
in	O
localizing	O
Yck1p	S-Protein
-	O
Yck2p	S-Protein
to	O
the	O
plasma	O
membrane	O
,	O
a	O
localization	O
that	O
depends	O
on	O
prenylation	O
of	O
C	O
-	O
terminal	O
dicysteinyl	O
motifs	O
.	O

In	O
akr1Delta	S-Protein
cells	O
,	O
Yck2p	S-Protein
is	O
mislocalized	O
,	O
showing	O
a	O
diffuse	O
cytoplasmic	O
localization	O
identical	O
to	O
that	O
seen	O
for	O
a	O
Yck2p	S-Protein
mutant	O
that	O
lacks	O
the	O
C	O
-	O
terminal	O
Cys	O
-	O
Cys	O
,	O
indicating	O
a	O
likely	O
Akr1p	S-Protein
requirement	O
for	O
the	O
lipid	O
modification	O
of	O
Yck2p	S-Protein
,	O
for	O
prenylation	O
,	O
or	O
possibly	O
for	O
palmitoylation	O
.	O

The	O
Drosophila	O
UBC9	S-Protein
homologue	O
lesswright	S-Protein
mediates	O
the	O
disjunction	O
of	O
homologues	O
in	O
meiosis	O
I	O
.	O

BACKGROUND	O
:	O
In	O
Saccharomyces	O
cerevisiae	O
and	O
other	O
organisms	O
,	O
the	O
UBC9	S-Protein
(	O
ubiquitin	B-Protein
-	I-Protein
conjugating	I-Protein
9	E-Protein
)	O
protein	O
modifies	O
the	O
function	O
of	O
many	O
different	O
target	O
proteins	O
through	O
covalent	O
attachment	O
of	O
the	O
ubiquitin	O
-	O
like	O
protein	O
SMT	B-Protein
-	I-Protein
3	E-Protein
/	O
SUMO	O
.	O

RESULTS	O
:	O
Using	O
a	O
second	O
-	O
site	O
suppression	O
screen	O
of	O
a	O
mutation	O
in	O
the	O
nod	O
locus	O
with	O
a	O
variable	O
meiotic	O
phenotype	O
,	O
we	O
have	O
identified	O
mutations	O
in	O
the	O
Drosophila	O
melanogaster	O
UBC9	S-Protein
homologue	O
,	O
encoded	O
by	O
the	O
gene	O
lesswright	S-Protein
(	O
lwr	S-Protein
)	O
.	O
lwr	S-Protein
mutations	O
dominantly	O
suppress	O
the	O
nondisjunction	O
and	O
cytological	O
defects	O
of	O
female	O
meiotic	O
mutations	O
that	O
affect	O
spindle	O
formation	O
.	O

The	O
lwr	S-Protein
lethal	O
phenotype	O
is	O
rescued	O
by	O
a	O
Drosophila	O
UBC9	S-Protein
/	O
lwr	S-Protein
transgene	O
.	O

CONCLUSIONS	O
:	O
We	O
suggest	O
that	O
LWR	S-Protein
mediates	O
the	O
dissociation	O
of	O
heterochromatic	O
regions	O
of	O
homologues	O
at	O
the	O
end	O
of	O
meiotic	O
prophase	O
I	O
.	O

Our	O
model	O
proposes	O
that	O
when	O
there	O
is	O
less	O
LWR	S-Protein
protein	O
,	O
homologues	O
remain	O
together	O
longer	O
,	O
allowing	O
for	O
more	O
normal	O
spindle	O
formation	O
in	O
mutant	O
backgrounds	O
and	O
therefore	O
more	O
accurate	O
meiotic	O
chromosome	O
segregation	O
.	O

Solution	O
structure	O
of	O
the	O
lipoyl	O
domain	O
of	O
the	O
chimeric	O
dihydrolipoyl	O
dehydrogenase	O
P64K	S-Protein
from	O
Neisseria	O
meningitidis	O
.	O

The	O
antigenic	O
P64K	S-Protein
protein	O
from	O
the	O
pathogenic	O
bacterium	O
Neisseria	O
meningitidis	O
is	O
found	O
in	O
the	O
outer	O
membrane	O
of	O
the	O
cell	O
,	O
and	O
consists	O
of	O
two	O
parts	O
:	O
an	O
81	O
-	O
residue	O
N	O
-	O
terminal	O
region	O
and	O
a	O
482	O
-	O
residue	O
C	O
-	O
terminal	O
region	O
.	O

The	O
amino	O
-	O
acid	O
sequence	O
of	O
the	O
N	O
-	O
terminal	O
region	O
is	O
homologous	O
with	O
the	O
lipoyl	O
domains	O
of	O
the	O
dihydrolipoyl	O
acyltransferase	O
(	O
E2	O
)	O
components	O
,	O
and	O
that	O
of	O
the	O
C	O
-	O
terminal	O
region	O
with	O
the	O
dihydrolipoyl	O
dehydrogenase	O
(	O
E3	O
)	O
components	O
,	O
of	O
2	O
-	O
oxo	O
acid	O
dehydrogenase	O
multienzyme	O
complexes	O
.	O

The	O
two	O
parts	O
are	O
separated	O
by	O
a	O
long	O
linker	O
region	O
,	O
similar	O
to	O
the	O
linker	O
regions	O
in	O
the	O
E2	O
chains	O
of	O
2	O
-	O
oxo	O
acid	O
dehydrogenase	O
complexes	O
,	O
and	O
it	O
is	O
likely	O
this	O
region	O
is	O
conformationally	O
flexible	O
.	O

A	O
subgene	O
encoding	O
the	O
P64K	S-Protein
lipoyl	O
domain	O
was	O
created	O
and	O
over	O
-	O
expressed	O
in	O
Escherichia	O
coli	O
.	O

The	O
product	O
was	O
capable	O
of	O
post	O
-	O
translational	O
modification	O
by	O
the	O
lipoate	B-Protein
protein	I-Protein
ligase	E-Protein
but	O
not	O
aberrant	O
modification	O
by	O
the	O
biotin	B-Protein
protein	I-Protein
ligase	E-Protein
of	O
E	O
.	O
coli	O
.	O

The	O
solution	O
structure	O
of	O
the	O
apo	O
-	O
domain	O
was	O
determined	O
by	O
means	O
of	O
heteronuclear	O
NMR	O
spectroscopy	O
and	O
found	O
to	O
be	O
a	O
flattened	O
beta	O
barrel	O
composed	O
of	O
two	O
four	O
-	O
stranded	O
antiparallel	O
beta	O
sheets	O
.	O

The	O
lysine	O
residue	O
that	O
becomes	O
lipoylated	O
is	O
in	O
an	O
exposed	O
beta	O
turn	O
that	O
,	O
from	O
a	O
[	O
1H	O
]	O
-	O
15N	O
heteronuclear	O
Overhauser	O
effect	O
experiment	O
,	O
appears	O
to	O
enjoy	O
substantial	O
local	O
motion	O
.	O

This	O
structure	O
of	O
a	O
lipoyl	O
domain	O
derived	O
from	O
a	O
dihydrolipoyl	O
dehydrogenase	O
resembles	O
that	O
of	O
lipoyl	O
domains	O
normally	O
found	O
as	O
part	O
of	O
the	O
dihydrolipoyl	O
acyltransferase	O
component	O
of	O
2	O
-	O
oxo	O
acid	O
dehydrogenase	O
complexes	O
and	O
will	O
assist	O
in	O
furthering	O
the	O
understanding	O
of	O
its	O
function	O
in	O
a	O
multienzyme	O
complex	O
and	O
in	O
the	O
membrane	O
-	O
bound	O
P64K	S-Protein
protein	O
itself	O
.	O

PARP	B-Protein
-	I-Protein
1	E-Protein
modifies	O
the	O
effectiveness	O
of	O
p53	S-Protein
-	O
mediated	O
DNA	O
damage	O
response	O
.	O

The	O
tumour	O
suppressor	O
protein	O
p53	S-Protein
plays	O
a	O
key	O
role	O
in	O
the	O
cell	O
'	O
s	O
decision	O
to	O
arrest	O
the	O
cell	O
cycle	O
or	O
undergo	O
apoptosis	O
following	O
a	O
genotoxic	O
insult	O
.	O

p53	S-Protein
is	O
stabilized	O
and	O
activated	O
after	O
DNA	O
damage	O
,	O
however	O
the	O
cascade	O
of	O
events	O
signalling	O
from	O
DNA	O
lesions	O
to	O
p53	S-Protein
stabilization	O
and	O
activation	O
is	O
still	O
controversial	O
.	O

Poly	O
(	O
ADP	O
-	O
ribosylation	O
)	O
of	O
different	O
nuclear	O
acceptors	O
by	O
PARP	B-Protein
-	I-Protein
1	E-Protein
is	O
an	O
early	O
event	O
when	O
a	O
single	O
strand	O
DNA	O
lesion	O
is	O
produced	O
.	O

We	O
present	O
here	O
evidences	O
that	O
interplay	O
between	O
PARP	B-Protein
-	I-Protein
1	E-Protein
and	O
p53	S-Protein
is	O
dependent	O
on	O
the	O
type	O
of	O
damage	O
induced	O
to	O
DNA	O
.	O

Primary	O
mouse	O
embryonic	O
fibroblasts	O
derived	O
from	O
parp	B-Protein
-	I-Protein
1	E-Protein
-	O
/	O
-	O
mice	O
exhibited	O
decreased	O
p53	S-Protein
accumulation	O
and	O
activation	O
following	O
gamma	O
-	O
irradiation	O
compared	O
to	O
parp	B-Protein
-	I-Protein
1	E-Protein
proficient	O
cells	O
.	O

On	O
the	O
other	O
hand	O
,	O
treatment	O
with	O
the	O
single	O
alkylating	O
agent	O
2	O
'	O
-	O
methyl	O
-	O
2	O
'	O
-	O
nitrose	O
-	O
urea	O
(	O
MNU	O
)	O
,	O
resulted	O
in	O
the	O
rapid	O
and	O
sustained	O
accumulation	O
and	O
activation	O
of	O
p53	S-Protein
in	O
parp	B-Protein
-	I-Protein
1	E-Protein
-	O
deficient	O
cells	O
,	O
while	O
very	O
little	O
accumulation	O
was	O
observed	O
in	O
parp	B-Protein
-	I-Protein
1	E-Protein
+	O
/	O
+	O
cells	O
.	O

After	O
IR	O
,	O
the	O
turnover	O
of	O
the	O
p53	S-Protein
inhibitory	O
protein	O
MDM	B-Protein
-	I-Protein
2	E-Protein
is	O
perturbed	O
and	O
the	O
level	O
of	O
phosphorylation	O
of	O
p53	S-Protein
at	O
serine	O
-	O
15	O
is	O
blunted	O
in	O
parp	B-Protein
-	I-Protein
1	E-Protein
-	O
/	O
-	O
cells	O
.	O

PARP	B-Protein
-	I-Protein
1	E-Protein
is	O
determinant	O
in	O
the	O
cytotoxic	O
response	O
to	O
alkylating	O
agents	O
but	O
only	O
partially	O
contributes	O
to	O
radiation	O
-	O
induced	O
cell	O
killing	O
,	O
as	O
determined	O
by	O
colony	O
forming	O
assay	O
.	O

Altogether	O
,	O
these	O
results	O
suggest	O
that	O
PARP	B-Protein
-	I-Protein
1	E-Protein
participates	O
in	O
the	O
p53	S-Protein
response	O
following	O
irradiation	O
,	O
resides	O
upstream	O
of	O
p53	S-Protein
and	O
indirectly	O
modulates	O
the	O
level	O
of	O
phosphorylation	O
of	O
key	O
substrates	O
in	O
this	O
pathway	O
while	O
treatment	O
with	O
MNU	O
results	O
in	O
an	O
enhanced	O
p53	S-Protein
-	O
mediated	O
response	O
in	O
parp	B-Protein
-	I-Protein
1	E-Protein
-	O
null	O
cells	O
.	O

[	O
Monoclonal	O
antibodies	O
against	O
protein	O
Daxx	S-Protein
and	O
its	O
localization	O
in	O
nuclear	O
domains	O
10	O
]	O

Nuclear	O
domains	O
10	O
(	O
ND10	O
)	O
were	O
first	O
detected	O
occasionally	O
using	O
antibodies	O
to	O
an	O
antigen	O
of	O
unknown	O
nature	O
(	O
Ascoli	O
,	O
Maul	O
,	O
1991	O
)	O
.	O

Further	O
on	O
it	O
was	O
shown	O
that	O
ND10	O
were	O
sites	O
of	O
locality	O
of	O
the	O
number	O
of	O
proteins	O
(	O
PML	S-Protein
,	O
Sp	B-Protein
100	E-Protein
,	O
pRB	S-Protein
)	O
(	O
Sterndorf	O
et	O
al	O
.	O
,	O
1992	O
;	O
Kamitani	O
et	O
al	O
.	O
,	O
1998	O
)	O
,	O
the	O
majority	O
of	O
which	O
are	O
modified	O
with	O
ubiquitin	S-Protein
-	O
like	O
small	O
proteins	O
-	O
modifiers	O
(	O
SUMO	O
)	O
(	O
Ishov	O
,	O
Maul	O
,	O
1996	O
)	O
.	O

In	O
addition	O
,	O
it	O
was	O
shown	O
that	O
ND10	O
were	O
sites	O
of	O
primary	O
localization	O
,	O
transcription	O
and	O
replication	O
of	O
some	O
DNA	O
-	O
viruses	O
(	O
SV40	O
,	O
virus	O
of	O
simple	O
herpes	O
1	O
,	O
adenovirus	O
5	O
)	O
(	O
Ishov	O
,	O
Maul	O
,	O
1996	O
;	O
Ishov	O
et	O
al	O
.	O
,	O
1997	O
)	O
.	O

Except	O
for	O
SV40	O
,	O
these	O
viruses	O
produce	O
proteins	O
able	O
to	O
modify	O
ND10	O
,	O
or	O
leading	O
to	O
degradation	O
of	O
ND10	O
-	O
associated	O
proteins	O
(	O
Maul	O
et	O
al	O
.	O
,	O
1993	O
;	O
Maul	O
,	O
Everett	O
,	O
1994	O
)	O
.	O

This	O
degradation	O
is	O
accompanied	O
with	O
protein	O
desumofication	O
and	O
,	O
later	O
,	O
with	O
hydrolysis	O
on	O
the	O
ubiquitin	S-Protein
-	O
proteosomal	O
way	O
(	O
Everett	O
et	O
al	O
.	O
,	O
1998	O
,	O
1999	O
)	O
.	O

Cell	O
incubation	O
with	O
interferon	O
leads	O
to	O
augmentation	O
of	O
the	O
number	O
and	O
dimension	O
of	O
ND10	O
owing	O
to	O
increased	O
expression	O
of	O
Sp100	S-Protein
and	O
PML	S-Protein
(	O
Lavau	O
et	O
al	O
.	O
,	O
1995	O
;	O
Grotzinger	O
et	O
al	O
.	O
,	O
1996	O
)	O
.	O

In	O
all	O
,	O
these	O
data	O
make	O
it	O
possible	O
to	O
put	O
forward	O
a	O
hypothesis	O
that	O
ND10	O
may	O
represent	O
a	O
peculiar	O
cell	O
storage	O
(	O
"	O
d	O
e	O
p	O
o	O
t	O
"	O
)	O
of	O
proteins	O
regulated	O
according	O
to	O
the	O
"	O
accumulation	O
-	O
drop	O
"	O
principle	O
(	O
Ishov	O
et	O
al	O
.	O
,	O
1997	O
;	O
Maul	O
,	O
1998	O
)	O
.	O

However	O
,	O
this	O
hypothesis	O
requires	O
further	O
factual	O
grounds	O
.	O

The	O
SUMO	O
ubiquitin	S-Protein
-	O
protein	O
isopeptide	O
ligase	O
family	O
member	O
Miz1	S-Protein
/	O
PIASxbeta	S-Protein
/	O
Siz2	S-Protein
is	O
a	O
transcriptional	O
cofactor	O
for	O
TFII	B-Protein
-	I-Protein
I	E-Protein
.	O

We	O
have	O
shown	O
previously	O
that	O
a	O
TFII	B-Protein
-	I-Protein
I	E-Protein
-	O
related	O
protein	O
,	O
hMusTRD1	B-Protein
/	I-Protein
BEN	E-Protein
,	O
represses	O
transcriptional	O
activity	O
of	O
TFII	B-Protein
-	I-Protein
I	E-Protein
.	O

The	O
repression	O
by	O
hMusTRD1	B-Protein
/	I-Protein
BEN	E-Protein
was	O
hypothesized	O
to	O
occur	O
via	O
a	O
two	O
-	O
step	O
competition	O
mechanism	O
involving	O
a	O
cytoplasmic	O
shuttling	O
factor	O
and	O
a	O
nuclear	O
cofactor	O
required	O
for	O
transcriptional	O
activation	O
of	O
TFII	B-Protein
-	I-Protein
I	E-Protein
.	O

Employing	O
a	O
two	O
-	O
hybrid	O
approach	O
with	O
both	O
yeast	O
genomic	O
and	O
mouse	O
cDNA	O
libraries	O
in	O
parallel	O
,	O
we	O
have	O
identified	O
the	O
RING	O
-	O
like	O
zinc	O
finger	O
containing	O
Miz1	S-Protein
/	O
PIASxbeta	S-Protein
/	O
Siz2	S-Protein
,	O
which	O
is	O
a	O
ubiquitin	S-Protein
-	O
protein	O
isopeptide	O
ligase	O
in	O
the	O
SUMO	O
pathway	O
,	O
as	O
the	O
potential	O
nuclear	O
cofactor	O
that	O
interacts	O
with	O
both	O
TFII	B-Protein
-	I-Protein
I	E-Protein
and	O
hMusTRD1	B-Protein
/	I-Protein
BEN	E-Protein
.	O

Our	O
conclusion	O
is	O
based	O
on	O
the	O
following	O
observations	O
.	O

First	O
,	O
the	O
interactions	O
are	O
biochemically	O
confirmed	O
in	O
mammalian	O
cells	O
where	O
Miz1	S-Protein
/	O
mPIASxbeta	S-Protein
interacts	O
with	O
both	O
TFII	B-Protein
-	I-Protein
I	E-Protein
and	O
hMusTRD1	B-Protein
/	I-Protein
BEN	E-Protein
when	O
these	O
proteins	O
are	O
ectopically	O
co	O
-	O
expressed	O
.	O

Second	O
,	O
co	O
-	O
expression	O
of	O
a	O
nuclear	O
localization	O
signal	O
-	O
deficient	O
mutant	O
of	O
Miz1	S-Protein
/	O
mPIASxbeta	S-Protein
with	O
wild	O
type	O
TFII	B-Protein
-	I-Protein
I	E-Protein
fails	O
to	O
alter	O
the	O
subcellular	O
localization	O
of	O
the	O
former	O
.	O

Finally	O
,	O
ectopically	O
expressed	O
Miz1	S-Protein
/	O
mPIASxbeta	S-Protein
augments	O
the	O
transcriptional	O
activity	O
of	O
TFII	B-Protein
-	I-Protein
I	E-Protein
and	O
relieves	O
the	O
repression	O
exerted	O
by	O
a	O
mutant	O
hMusTRD1	B-Protein
/	I-Protein
BEN	E-Protein
that	O
co	O
-	O
localized	O
with	O
TFII	B-Protein
-	I-Protein
I	E-Protein
in	O
the	O
nucleus	O
.	O

Modulation	O
of	O
p120E4F	S-Protein
transcriptional	O
activity	O
by	O
the	O
Gam1	S-Protein
adenoviral	O
early	O
protein	O
.	O

Gam1	S-Protein
,	O
an	O
early	O
adenoviral	O
CELO	O
protein	O
,	O
is	O
required	O
for	O
viral	O
replication	O
.	O

Consistent	O
with	O
its	O
ability	O
to	O
inhibit	O
histone	S-Protein
deacetylation	O
by	O
HDAC1	S-Protein
,	O
Gam1	S-Protein
activates	O
transcription	O
.	O

In	O
this	O
report	O
,	O
we	O
identify	O
the	O
cellular	O
transcription	O
factor	O
p120	S-Protein
(	O
E4F	S-Protein
)	O
as	O
a	O
Gam1	S-Protein
interaction	O
partner	O
.	O

p120	S-Protein
(	O
E4F	S-Protein
)	O
is	O
a	O
low	O
-	O
abundance	O
transcription	O
factor	O
that	O
represses	O
the	O
adenovirus	O
E4	S-Protein
promoter	O
.	O

Here	O
we	O
demonstrate	O
that	O
p120	S-Protein
(	O
E4F	S-Protein
)	O
interacts	O
with	O
HDAC1	S-Protein
in	O
vivo	O
and	O
in	O
vitro	O
,	O
and	O
that	O
E4F	S-Protein
-	O
mediated	O
transcriptional	O
repression	O
is	O
alleviated	O
by	O
the	O
HDAC	O
inhibitor	O
trichostatin	O
A	O
or	O
by	O
overexpressing	O
Gam1	S-Protein
.	O

A	O
mutant	O
E4	S-Protein
promoter	O
unresponsive	O
to	O
E4F	S-Protein
-	O
mediated	O
transcriptional	O
repression	O
is	O
also	O
not	O
stimulated	O
by	O
Gam1	S-Protein
.	O

Moreover	O
,	O
our	O
cofractionation	O
experiments	O
demonstrate	O
that	O
p120	S-Protein
(	O
E4F	S-Protein
)	O
,	O
HDAC1	S-Protein
and	O
Gam1	S-Protein
may	O
be	O
concomitantly	O
present	O
in	O
protein	O
complexes	O
.	O

We	O
conclude	O
that	O
Gam1	S-Protein
activates	O
E4	S-Protein
-	O
dependent	O
transcription	O
possibly	O
by	O
inactivating	O
HDAC1	S-Protein
.	O

The	O
B	O
cell	O
-	O
specific	O
major	O
raft	O
protein	O
,	O
Raftlin	S-Protein
,	O
is	O
necessary	O
for	O
the	O
integrity	O
of	O
lipid	O
raft	O
and	O
BCR	O
signal	O
transduction	O
.	O

Recent	O
evidence	O
indicates	O
that	O
membrane	O
microdomains	O
,	O
termed	O
lipid	O
rafts	O
,	O
have	O
a	O
role	O
in	O
B	O
-	O
cell	O
activation	O
as	O
platforms	O
for	O
B	O
-	O
cell	O
antigen	O
receptor	O
(	O
BCR	O
)	O
signal	O
initiation	O
.	O

To	O
gain	O
an	O
insight	O
into	O
the	O
possible	O
functioning	O
of	O
lipid	O
rafts	O
in	O
B	O
cells	O
,	O
we	O
applied	O
liquid	O
chromatography	O
electrospray	O
ionization	O
tandem	O
mass	O
spectrometry	O
(	O
LC	O
-	O
ESI	O
-	O
MS	O
/	O
MS	O
)	O
methodologies	O
to	O
the	O
identification	O
of	O
proteins	O
that	O
co	O
-	O
purified	O
with	O
lipid	O
rafts	O
of	O
Raji	O
cells	O
.	O

Among	O
these	O
raft	O
proteins	O
,	O
we	O
characterized	O
a	O
novel	O
protein	O
termed	O
Raftlin	S-Protein
(	O
raft	B-Protein
-	I-Protein
linking	I-Protein
protein	E-Protein
)	O
.	O

Like	O
the	O
Src	O
family	O
kinase	O
,	O
Raftlin	S-Protein
is	O
localized	O
exclusively	O
in	O
lipid	O
rafts	O
by	O
fatty	O
acylation	O
of	O
N	O
-	O
terminal	O
Gly2	O
and	O
Cys3	O
,	O
and	O
is	O
co	O
-	O
localized	O
with	O
BCR	O
before	O
and	O
after	O
BCR	O
stimulation	O
.	O

Disruption	O
of	O
the	O
Raftlin	S-Protein
gene	O
in	O
the	O
DT40	O
B	O
-	O
cell	O
line	O
resulted	O
in	O
a	O
marked	O
reduction	O
in	O
the	O
quantity	O
of	O
lipid	O
raft	O
components	O
,	O
including	O
Lyn	S-Protein
and	O
ganglioside	O
GM1	O
,	O
while	O
overexpression	O
of	O
Raftlin	S-Protein
increased	O
the	O
content	O
of	O
raft	O
protein	O
.	O

Moreover	O
,	O
BCR	O
-	O
mediated	O
tyrosine	O
phosphorylation	O
and	O
calcium	O
mobilization	O
were	O
impaired	O
by	O
the	O
lack	O
of	O
Raftlin	S-Protein
and	O
actually	O
potentiated	O
by	O
overexpression	O
of	O
Raftlin	S-Protein
.	O

These	O
data	O
suggest	O
that	O
Raftlin	S-Protein
plays	O
a	O
pivotal	O
role	O
in	O
the	O
formation	O
and	O
/	O
or	O
maintenance	O
of	O
lipid	O
rafts	O
,	O
therefore	O
regulating	O
BCR	O
-	O
mediated	O
signaling	O
.	O

Molecular	O
evolution	O
of	O
the	O
Rab	B-Protein
-	I-Protein
escort	I-Protein
-	I-Protein
protein	E-Protein
/	O
guanine	B-Protein
-	I-Protein
nucleotide	I-Protein
-	I-Protein
dissociation	I-Protein
-	I-Protein
inhibitor	E-Protein
superfamily	O
.	O

Prenylation	O
of	O
Rab	O
GTPases	O
regulating	O
vesicle	O
traffic	O
by	O
Rab	O
geranylgeranyltransferase	O
(	O
RabGGTase	O
)	O
requires	O
a	O
complex	O
formed	O
by	O
the	O
association	O
of	O
newly	O
synthesized	O
Rab	O
proteins	O
with	O
Rab	B-Protein
-	I-Protein
escort	I-Protein
-	I-Protein
protein	E-Protein
(	O
REP	S-Protein
)	O
,	O
the	O
choroideremia	S-Protein
-	O
gene	O
-	O
product	O
that	O
is	O
mutated	O
in	O
disease	O
,	O
leading	O
to	O
loss	O
of	O
vision	O
.	O

After	O
delivery	O
to	O
the	O
membrane	O
by	O
the	O
REP	S-Protein
-	O
Rab	O
complex	O
,	O
subsequent	O
recycling	O
to	O
the	O
cytosol	O
requires	O
the	O
REP	S-Protein
-	O
related	O
guanine	B-Protein
-	I-Protein
nucleotide	I-Protein
-	I-Protein
dissociation	I-Protein
-	I-Protein
inhibitor	E-Protein
(	O
GDI	S-Protein
)	O
.	O

Although	O
REP	S-Protein
and	O
GDI	S-Protein
share	O
common	O
Rab	O
-	O
binding	O
properties	O
,	O
GDI	S-Protein
cannot	O
assist	O
in	O
Rab	O
prenylation	O
and	O
REP	S-Protein
cannot	O
retrieve	O
Rab	O
proteins	O
from	O
the	O
membranes	O
.	O

We	O
have	O
now	O
isolated	O
REP	S-Protein
mutant	O
proteins	O
that	O
are	O
able	O
to	O
partially	O
function	O
as	O
both	O
REP	S-Protein
and	O
GDI	S-Protein
.	O

These	O
results	O
provide	O
molecular	O
insight	O
into	O
the	O
functional	O
and	O
evolutionary	O
organization	O
of	O
the	O
REP	S-Protein
/	O
GDI	S-Protein
superfamily	O
.	O

Synthesis	O
of	O
functionalized	O
rab	O
GTPases	O
by	O
a	O
combination	O
of	O
solution	O
-	O
or	O
solid	O
-	O
phase	O
lipopeptide	O
synthesis	O
with	O
expressed	O
protein	O
ligation	O
.	O

Prenylated	O
proteins	O
with	O
non	O
-	O
native	O
functionalities	O
are	O
generally	O
very	O
difficult	O
to	O
obtain	O
by	O
recombinant	O
or	O
enzymatic	O
means	O
.	O

The	O
semisynthesis	O
of	O
preparative	O
amounts	O
of	O
prenylated	O
Rab	O
guanosine	O
triphosphatases	O
(	O
GTPases	O
)	O
from	O
recombinant	O
proteins	O
and	O
synthetic	O
prenylated	O
peptides	O
depends	O
largely	O
on	O
the	O
availability	O
of	O
functionalised	O
prenylated	O
peptides	O
corresponding	O
to	O
the	O
proteins	O
'	O
native	O
structure	O
or	O
modifications	O
thereof	O
.	O

Here	O
,	O
we	O
describe	O
and	O
compare	O
solution	O
-	O
phase	O
and	O
solid	O
-	O
phase	O
strategies	O
for	O
the	O
generation	O
of	O
peptides	O
corresponding	O
to	O
the	O
prenylated	O
C	O
terminus	O
of	O
Rab7	S-Protein
GTPase	O
.	O

The	O
solid	O
-	O
phase	O
with	O
utilisation	O
of	O
a	O
hydrazide	O
linker	O
emerges	O
as	O
the	O
more	O
favourable	O
approach	O
.	O

It	O
allows	O
a	O
fast	O
and	O
practical	O
synthesis	O
of	O
pure	O
peptides	O
and	O
gives	O
a	O
high	O
degree	O
of	O
flexibility	O
in	O
their	O
modification	O
.	O

To	O
facilitate	O
the	O
analysis	O
of	O
semisynthetic	O
proteins	O
,	O
the	O
synthesised	O
peptides	O
were	O
equipped	O
with	O
a	O
fluorescent	O
group	O
.	O

Using	O
the	O
described	O
approach	O
,	O
we	O
introduced	O
fluorophores	O
at	O
several	O
different	O
positions	O
of	O
the	O
Rab7	S-Protein
C	O
terminus	O
.	O

The	O
position	O
of	O
the	O
incorporated	O
fluorescent	O
groups	O
in	O
the	O
peptides	O
did	O
not	O
influence	O
the	O
protein	O
-	O
ligation	O
reaction	O
,	O
as	O
the	O
generated	O
peptides	O
could	O
be	O
ligated	O
onto	O
thioester	O
-	O
tagged	O
Rab7	S-Protein
.	O

However	O
,	O
it	O
was	O
found	O
that	O
the	O
positioning	O
of	O
the	O
fluorescent	O
group	O
had	O
an	O
influence	O
on	O
the	O
functionality	O
of	O
the	O
Rab7	S-Protein
proteins	O
;	O
analysis	O
of	O
the	O
interaction	O
of	O
the	O
semisynthetic	O
Rab7	S-Protein
proteins	O
with	O
REP	O
(	O
Rab	O
escort	O
protein	O
)	O
and	O
GDI	O
(	O
guanosine	O
diphosphate	O
dissociation	O
inhibitor	O
)	O
molecules	O
revealed	O
that	O
modification	O
of	O
the	O
peptide	O
side	O
chains	O
or	O
of	O
the	O
C	O
-	O
terminal	O
isoprenoid	O
did	O
not	O
significantly	O
interfere	O
with	O
complex	O
formation	O
.	O

However	O
,	O
functionalisation	O
of	O
the	O
C	O
terminus	O
was	O
found	O
to	O
have	O
an	O
adverse	O
effect	O
on	O
complex	O
formation	O
and	O
stability	O
,	O
possibly	O
reflecting	O
low	O
structural	O
flexibility	O
of	O
the	O
Rab	O
GDI	O
/	O
REP	O
molecules	O
in	O
the	O
vicinity	O
of	O
the	O
lipid	O
-	O
binding	O
site	O
.	O

Application	O
of	O
protein	O
semisynthesis	O
for	O
the	O
construction	O
of	O
functionalized	O
posttranslationally	O
modified	O
rab	O
GTPases	O
.	O

Rab	O
GTPases	O
represent	O
a	O
family	O
of	O
key	O
membrane	O
traffic	O
regulators	O
in	O
eukaryotic	O
cells	O
.	O

To	O
exert	O
their	O
function	O
,	O
Rab	O
proteins	O
must	O
be	O
modified	O
with	O
one	O
or	O
two	O
geranylgeranyl	O
moieties	O
.	O

This	O
modification	O
enables	O
them	O
to	O
reversibly	O
associate	O
with	O
intracellular	O
membranes	O
.	O

In	O
vivo	O
the	O
newly	O
synthesized	O
Rab	O
proteins	O
are	O
recruited	O
by	O
Rab	O
escort	O
protein	O
(	O
REP	O
)	O
that	O
presents	O
them	O
to	O
the	O
Rab	O
geranylgeranyl	O
transferase	O
(	O
Rab	O
GGTase	O
)	O
,	O
which	O
transfers	O
one	O
or	O
two	O
geranylgeranyl	O
moieties	O
to	O
the	O
C	O
-	O
terminal	O
cysteines	O
.	O

Detailed	O
understanding	O
of	O
the	O
mechanism	O
of	O
prenylation	O
reaction	O
and	O
subsequent	O
membrane	O
delivery	O
of	O
Rab	O
proteins	O
to	O
the	O
target	O
membranes	O
were	O
hampered	O
by	O
lack	O
of	O
efficient	O
technologies	O
for	O
the	O
generation	O
of	O
preparative	O
amounts	O
of	O
prenylated	O
Rab	O
GTPases	O
.	O

To	O
circumvent	O
this	O
problem	O
,	O
we	O
developed	O
an	O
approach	O
that	O
combines	O
recombinant	O
protein	O
production	O
,	O
chemical	O
synthesis	O
of	O
lipidated	O
peptides	O
with	O
precisely	O
designed	O
and	O
readily	O
alterable	O
structures	O
,	O
and	O
a	O
technique	O
for	O
peptide	O
-	O
to	O
-	O
protein	O
ligation	O
.	O

Using	O
this	O
approach	O
,	O
we	O
generated	O
a	O
number	O
of	O
semisynthetic	O
prenylated	O
Rab	O
GTPases	O
.	O

Some	O
of	O
the	O
proteins	O
were	O
also	O
supplemented	O
with	O
fluorophores	O
,	O
which	O
enabled	O
us	O
to	O
develop	O
a	O
fluorescence	O
-	O
based	O
in	O
vitro	O
prenylation	O
assay	O
.	O

The	O
approach	O
described	O
allows	O
production	O
of	O
preparative	O
amounts	O
of	O
prenylated	O
GTPases	O
,	O
which	O
was	O
demonstrated	O
by	O
generation	O
and	O
crystallization	O
of	O
a	O
monoprenylated	O
YPT1	S-Protein
:	O
Rab	B-Protein
GDI	E-Protein
complex	O
.	O

Simple	O
histone	S-Protein
acetylation	O
plays	O
a	O
complex	O
role	O
in	O
the	O
regulation	O
of	O
gene	O
expression	O
.	O

Eukaryotic	O
DNA	O
is	O
packaged	O
into	O
chromatin	O
by	O
histone	S-Protein
proteins	O
,	O
which	O
assemble	O
the	O
DNA	O
into	O
an	O
organized	O
,	O
higher	O
-	O
order	O
structure	O
.	O

The	O
precise	O
organization	O
of	O
chromatin	O
is	O
essential	O
for	O
faithful	O
execution	O
of	O
DNA	O
-	O
mediated	O
reactions	O
such	O
as	O
transcription	O
,	O
DNA	O
replication	O
,	O
DNA	O
repair	O
and	O
DNA	O
recombination	O
.	O

The	O
organization	O
of	O
chromatin	O
is	O
considered	O
to	O
be	O
regulated	O
by	O
a	O
variety	O
of	O
post	O
-	O
translational	O
modifications	O
of	O
histones	S-Protein
,	O
such	O
as	O
acetylation	O
,	O
methylation	O
,	O
phosphorylation	O
,	O
ubiquitination	O
,	O
SUMOylation	O
and	O
poly	O
-	O
ADP	O
-	O
ribosylation	O
.	O

The	O
relationship	O
between	O
histone	S-Protein
acetylation	O
and	O
gene	O
expression	O
was	O
first	O
observed	O
in	O
1964	O
.	O

Since	O
then	O
,	O
a	O
great	O
deal	O
of	O
evidence	O
has	O
accumulated	O
showing	O
that	O
not	O
only	O
transcription	O
but	O
other	O
DNA	O
-	O
mediated	O
reactions	O
also	O
are	O
regulated	O
by	O
histone	S-Protein
acetylation	O
.	O

With	O
regard	O
to	O
the	O
putative	O
mechanism	O
(	O
s	O
)	O
by	O
which	O
histone	S-Protein
acetylation	O
regulates	O
the	O
flow	O
of	O
genetic	O
information	O
,	O
site	O
-	O
specific	O
modification	O
and	O
recognition	O
of	O
acetylated	O
histone	S-Protein
/	O
DNA	O
complexes	O
have	O
been	O
postulated	O
.	O

Elucidation	O
of	O
the	O
downstream	O
effects	O
of	O
histone	S-Protein
modification	O
,	O
as	O
well	O
as	O
the	O
identification	O
,	O
isolation	O
and	O
characterization	O
of	O
the	O
relevant	O
factors	O
involved	O
,	O
have	O
aided	O
in	O
our	O
understanding	O
of	O
the	O
mechanisms	O
of	O
regulation	O
of	O
DNA	O
activity	O
by	O
histones	S-Protein
.	O

Currently	O
,	O
state	O
-	O
of	O
-	O
the	O
-	O
art	O
technologies	O
that	O
enable	O
genome	O
-	O
wide	O
analysis	O
are	O
allowing	O
insight	O
into	O
a	O
critical	O
and	O
interesting	O
question	O
in	O
eukaryotic	O
transcription	O
:	O
are	O
the	O
principles	O
that	O
govern	O
transcription	O
of	O
individual	O
gene	O
loci	O
applicable	O
to	O
the	O
genome	O
as	O
a	O
whole	O
?	O

Here	O
,	O
we	O
review	O
the	O
recent	O
progress	O
on	O
histone	S-Protein
modifications	O
,	O
with	O
an	O
emphasis	O
on	O
the	O
role	O
of	O
histone	S-Protein
acetylation	O
in	O
gene	O
expression	O
.	O

PIAS3	S-Protein
induction	O
of	O
PRB	S-Protein
sumoylation	O
represses	O
PRB	S-Protein
transactivation	O
by	O
destabilizing	O
its	O
retention	O
in	O
the	O
nucleus	O
.	O

Progesterone	B-Protein
receptor	E-Protein
(	O
PR	S-Protein
)	O
plays	O
a	O
critical	O
role	O
in	O
cell	O
proliferation	O
and	O
differentiation	O
,	O
and	O
its	O
transcriptional	O
activity	O
is	O
known	O
to	O
be	O
modulated	O
by	O
cofactor	O
proteins	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
demonstrated	O
that	O
in	O
the	O
presence	O
of	O
progesterone	O
,	O
protein	B-Protein
inhibitor	I-Protein
of	I-Protein
activated	I-Protein
STAT	I-Protein
-	I-Protein
3	E-Protein
(	O
PIAS3	S-Protein
)	O
significantly	O
inhibited	O
the	O
PR	S-Protein
transcriptional	O
activity	O
and	O
the	O
expression	O
of	O
progesterone	O
-	O
responsive	O
genes	O
.	O

Reduction	O
of	O
endogenous	O
PIAS3	S-Protein
by	O
PIAS3	S-Protein
small	O
-	O
interfering	O
RNA	O
enhanced	O
PR	S-Protein
transactivation	O
in	O
a	O
ligand	O
-	O
dependent	O
manner	O
.	O

PIAS3	S-Protein
interacted	O
with	O
PR	S-Protein
both	O
in	O
vitro	O
and	O
in	O
vivo	O
and	O
the	O
interaction	O
was	O
enhanced	O
by	O
progesterone	O
.	O

Furthermore	O
,	O
our	O
findings	O
suggested	O
that	O
PIAS3	S-Protein
strongly	O
induced	O
PRB	S-Protein
sumoylation	O
at	O
three	O
sites	O
,	O
Lys	O
-	O
7	O
,	O
Lys	O
-	O
388	O
and	O
Lys	O
-	O
531	O
.	O

In	O
addition	O
,	O
novel	O
roles	O
in	O
PRB	S-Protein
nuclear	O
retention	O
and	O
transactivation	O
were	O
identified	O
for	O
these	O
sites	O
.	O

Our	O
data	O
also	O
suggested	O
that	O
PIAS3	S-Protein
was	O
recruited	O
in	O
a	O
largely	O
hormone	O
-	O
dependent	O
manner	O
in	O
response	O
to	O
a	O
progesterone	O
-	O
responsive	O
promoter	O
.	O

Finally	O
,	O
we	O
demonstrated	O
that	O
PIAS3	S-Protein
inhibited	O
the	O
DNA	O
-	O
binding	O
activity	O
of	O
PR	S-Protein
and	O
influenced	O
its	O
nuclear	O
export	O
as	O
well	O
as	O
PR	S-Protein
transactivation	O
.	O

Taken	O
together	O
,	O
these	O
data	O
strongly	O
suggested	O
that	O
PIAS3	S-Protein
played	O
an	O
important	O
physiological	O
role	O
in	O
PR	S-Protein
function	O
.	O

Herpes	O
simplex	O
virus	O
protein	O
UL11	S-Protein
but	O
not	O
UL51	S-Protein
is	O
associated	O
with	O
lipid	O
rafts	O
.	O

The	O
UL11	S-Protein
and	O
UL51	S-Protein
gene	O
products	O
of	O
herpes	O
simplex	O
virus	O
(	O
HSV	O
)	O
are	O
membrane	O
-	O
associated	O
tegument	O
proteins	O
that	O
are	O
incorporated	O
into	O
the	O
HSV	O
virion	O
.	O

UL11	S-Protein
and	O
UL51	S-Protein
are	O
conserved	O
throughout	O
the	O
herpesvirus	O
family	O
.	O

Both	O
UL11	S-Protein
and	O
UL51	S-Protein
,	O
either	O
singly	O
or	O
in	O
combination	O
,	O
are	O
involved	O
in	O
virion	O
envelopment	O
and	O
/	O
or	O
egress	O
.	O

Both	O
proteins	O
are	O
fatty	O
acylated	O
:	O
UL11	S-Protein
is	O
both	O
acylated	O
by	O
myristoic	O
and	O
palmitoic	O
acids	O
and	O
UL51	S-Protein
is	O
monoacylated	O
by	O
palmitoic	O
acid	O
.	O

Using	O
confocal	O
microscopy	O
and	O
sucrose	O
gradient	O
fractionations	O
in	O
transfected	O
or	O
HSV	O
-	O
infected	O
cells	O
,	O
we	O
found	O
that	O
HSV	O
-	O
2	O
UL11	S-Protein
but	O
not	O
UL51	S-Protein
was	O
associated	O
with	O
lipid	O
rafts	O
.	O

The	O
dual	O
acylation	O
of	O
UL11	S-Protein
was	O
necessary	O
for	O
lipid	O
raft	O
association	O
,	O
as	O
mutations	O
in	O
the	O
myristoylation	O
or	O
palmitoylation	O
sites	O
prevented	O
lipid	O
raft	O
association	O
.	O

These	O
differences	O
in	O
lipid	O
raft	O
association	O
may	O
contribute	O
to	O
the	O
functional	O
differences	O
between	O
UL11	S-Protein
and	O
UL51	S-Protein
.	O

Localization	O
of	O
the	O
TIG3	S-Protein
transglutaminase	O
interaction	O
domain	O
and	O
demonstration	O
that	O
the	O
amino	O
-	O
terminal	O
region	O
is	O
required	O
for	O
TIG3	S-Protein
function	O
as	O
a	O
keratinocyte	O
differentiation	O
regulator	O
.	O

Tazarotene	B-Protein
-	I-Protein
induced	I-Protein
gene	I-Protein
3	E-Protein
(	O
TIG3	S-Protein
)	O
regulates	O
keratinocyte	O
terminal	O
differentiation	O
by	O
activating	O
type	B-Protein
I	I-Protein
transglutaminase	E-Protein
(	O
TG1	S-Protein
)	O
.	O

TIG3	S-Protein
consists	O
of	O
an	O
amino	O
-	O
terminal	O
(	O
N	O
-	O
terminal	O
)	O
segment	O
,	O
that	O
encodes	O
several	O
conserved	O
motifs	O
,	O
and	O
a	O
carboxy	O
-	O
terminal	O
(	O
C	O
-	O
terminal	O
)	O
membrane	O
-	O
anchoring	O
domain	O
.	O

By	O
producing	O
a	O
series	O
of	O
truncation	O
mutants	O
that	O
remove	O
segments	O
of	O
the	O
N	O
-	O
terminal	O
region	O
,	O
and	O
monitoring	O
the	O
ability	O
of	O
each	O
mutant	O
to	O
co	O
-	O
precipitate	O
TG1	S-Protein
,	O
function	O
as	O
a	O
TG1	S-Protein
substrate	O
,	O
or	O
functionally	O
localize	O
with	O
TG1	O
in	O
cells	O
,	O
we	O
show	O
that	O
the	O
TIG3	S-Protein
domain	O
that	O
interacts	O
with	O
TG1	S-Protein
is	O
located	O
within	O
a	O
TIG3	S-Protein
segment	O
spanning	O
amino	O
acids	O
112	O
-	O
164	O
.	O

Although	O
they	O
bind	O
TG1	S-Protein
,	O
TIG3	S-Protein
mutants	O
lacking	O
the	O
conserved	O
N	O
-	O
terminal	O
region	O
drive	O
apoptosis	O
-	O
like	O
cell	O
death	O
characterized	O
by	O
cell	O
rounding	O
,	O
membrane	O
blebbing	O
,	O
cytochrome	B-Protein
c	E-Protein
release	O
,	O
procaspase	B-Protein
-	I-Protein
3	E-Protein
and	O
poly	O
(	O
ADP	O
-	O
ribose	O
)	O
polymerase	O
(	O
PARP	O
)	O
cleavage	O
,	O
and	O
reduced	O
p53	S-Protein
and	O
p21	S-Protein
levels	O
.	O

Compared	O
with	O
TIG3	S-Protein
,	O
these	O
truncated	O
mutants	O
have	O
an	O
increased	O
tendency	O
to	O
associate	O
with	O
membranes	O
.	O

A	O
mutant	O
lacking	O
the	O
C	O
-	O
terminal	O
membrane	O
-	O
anchoring	O
domain	O
is	O
inactive	O
.	O

These	O
findings	O
suggest	O
that	O
TIG3	S-Protein
interaction	O
with	O
TG1	S-Protein
does	O
not	O
require	O
the	O
N	O
-	O
terminal	O
conserved	O
domains	O
,	O
that	O
the	O
TIG3	S-Protein
N	O
-	O
terminal	O
region	O
is	O
required	O
for	O
TIG3	S-Protein
-	O
dependent	O
keratinocyte	O
differentiation	O
,	O
that	O
its	O
removal	O
converts	O
TIG3	S-Protein
into	O
a	O
proapoptotic	O
protein	O
,	O
and	O
that	O
this	O
change	O
in	O
action	O
of	O
TIG3	S-Protein
is	O
associated	O
with	O
an	O
intracellular	O
redistribution	O
.	O

Altered	O
pattern	O
of	O
Cul	B-Protein
-	I-Protein
1	E-Protein
protein	O
expression	O
and	O
neddylation	O
in	O
human	O
lung	O
tumours	O
:	O
relationships	O
with	O
CAND1	S-Protein
and	O
cyclin	B-Protein
E	E-Protein
protein	O
levels	O
.	O

The	O
Cul	B-Protein
-	I-Protein
1	E-Protein
protein	O
is	O
the	O
scaffold	O
element	O
of	O
SCF	O
complexes	O
that	O
are	O
involved	O
in	O
the	O
proteasomal	O
degradation	O
of	O
numerous	O
proteins	O
regulating	O
cell	O
cycle	O
progression	O
.	O

Owing	O
to	O
this	O
central	O
role	O
in	O
cell	O
growth	O
control	O
,	O
aberrant	O
expression	O
of	O
the	O
components	O
of	O
SCF	O
is	O
thought	O
to	O
play	O
a	O
role	O
during	O
tumourigenesis	O
.	O

Nothing	O
is	O
known	O
about	O
Cul	B-Protein
-	I-Protein
1	E-Protein
expression	O
in	O
human	O
tumours	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
analysed	O
its	O
status	O
in	O
a	O
series	O
of	O
128	O
human	O
lung	O
carcinomas	O
,	O
comprising	O
50	O
non	O
-	O
small	O
cell	O
lung	O
cancers	O
(	O
NSCLCs	O
;	O
29	O
squamous	O
cell	O
carcinomas	O
and	O
21	O
adenocarcinomas	O
)	O
and	O
78	O
neuroendocrine	O
(	O
NE	O
)	O
lung	O
tumours	O
(	O
24	O
typical	O
and	O
atypical	O
carcinoids	O
,	O
19	O
large	O
cell	O
NE	O
carcinomas	O
and	O
35	O
small	O
cell	O
lung	O
carcinomas	O
)	O
,	O
using	O
immunohistochemistry	O
.	O

We	O
report	O
for	O
the	O
first	O
time	O
an	O
altered	O
pattern	O
of	O
Cul	B-Protein
-	I-Protein
1	E-Protein
expression	O
in	O
human	O
tumours	O
;	O
indeed	O
,	O
we	O
show	O
that	O
Cul	B-Protein
-	I-Protein
1	E-Protein
expression	O
is	O
up	O
-	O
regulated	O
in	O
40	O
%	O
(	O
51	O
/	O
128	O
)	O
of	O
all	O
lung	O
tumours	O
as	O
compared	O
to	O
normal	O
lung	O
tissues	O
,	O
including	O
34	O
%	O
(	O
17	O
/	O
50	O
)	O
,	O
75	O
%	O
(	O
18	O
/	O
24	O
)	O
and	O
30	O
%	O
(	O
16	O
/	O
54	O
)	O
of	O
NSCLCs	O
,	O
carcinoids	O
and	O
high	O
grade	O
neuroendocrine	O
lung	O
carcinomas	O
,	O
respectively	O
.	O

Furthermore	O
,	O
we	O
demonstrate	O
that	O
high	O
levels	O
of	O
Cul	B-Protein
-	I-Protein
1	E-Protein
protein	O
are	O
associated	O
with	O
a	O
low	O
KI67	O
proliferative	O
index	O
(	O
p	O
=	O
0	O
.	O
005	O
)	O
and	O
with	O
a	O
decrease	O
in	O
the	O
cyclin	B-Protein
E	E-Protein
oncoprotein	O
(	O
p	O
=	O
0	O
.	O
0003	O
)	O
,	O
one	O
of	O
the	O
major	O
targets	O
of	O
SCF	O
complexes	O
.	O

These	O
data	O
suggest	O
that	O
up	O
-	O
regulation	O
of	O
Cul	B-Protein
-	I-Protein
1	E-Protein
could	O
protect	O
cells	O
from	O
hyperproliferative	O
signals	O
through	O
cyclin	B-Protein
E	E-Protein
down	O
-	O
regulation	O
.	O

Cul	B-Protein
-	I-Protein
1	E-Protein
is	O
modified	O
by	O
neddylation	O
,	O
a	O
post	O
-	O
translational	O
modification	O
that	O
grafts	O
ubiquitin	S-Protein
-	O
like	O
Nedd8	S-Protein
/	O
Rub1	S-Protein
residues	O
and	O
controls	O
Cul	B-Protein
-	I-Protein
1	E-Protein
activity	O
.	O

We	O
also	O
provide	O
evidence	O
that	O
neddylated	O
forms	O
of	O
Cul	B-Protein
-	I-Protein
1	E-Protein
are	O
specifically	O
expressed	O
in	O
high	O
-	O
grade	O
NE	O
lung	O
tumours	O
and	O
are	O
associated	O
with	O
down	O
-	O
regulation	O
of	O
the	O
Cul	B-Protein
-	I-Protein
1	E-Protein
inhibitor	O
CAND1	S-Protein
(	O
p	O
=	O
0	O
.	O
03	O
)	O
and	O
a	O
high	O
level	O
of	O
cyclin	B-Protein
E	E-Protein
(	O
p	O
=	O
0	O
.	O
0002	O
)	O
.	O

These	O
data	O
support	O
the	O
notion	O
that	O
alterations	O
in	O
the	O
Cul	B-Protein
-	I-Protein
1	E-Protein
neddylation	O
/	O
deneddylation	O
pathway	O
could	O
contribute	O
to	O
the	O
development	O
of	O
these	O
highly	O
aggressive	O
lung	O
tumours	O
.	O

Polyunsaturated	O
fatty	O
acids	O
block	O
platelet	O
-	O
activating	O
factor	O
-	O
induced	O
phosphatidylinositol	O
3	O
kinase	O
/	O
Akt	O
-	O
mediated	O
apoptosis	O
in	O
intestinal	O
epithelial	O
cells	O
.	O

We	O
have	O
shown	O
earlier	O
that	O
platelet	O
-	O
activating	O
factor	O
(	O
PAF	O
)	O
causes	O
apoptosis	O
in	O
enterocytes	O
via	O
a	O
mechanism	O
that	O
involves	O
Bax	S-Protein
translocation	O
to	O
mitochondria	O
,	O
followed	O
by	O
caspase	O
activation	O
and	O
DNA	O
fragmentation	O
.	O

Herein	O
we	O
report	O
that	O
,	O
in	O
rat	O
small	O
intestinal	O
epithelial	O
cells	O
(	O
IEC	O
-	O
6	O
)	O
,	O
these	O
downstream	O
apoptotic	O
effects	O
are	O
mediated	O
by	O
a	O
PAF	O
-	O
induced	O
inhibition	O
of	O
the	O
phosphatidylinositol	O
3	O
-	O
kinase	O
(	O
PI	O
3	O
-	O
kinase	O
)	O
/	O
protein	O
kinase	O
B	O
(	O
Akt	O
)	O
signaling	O
pathway	O
.	O

Treatment	O
with	O
PAF	O
results	O
in	O
rapid	O
dephosphorylation	O
of	O
Akt	O
,	O
phosphoinositide	B-Protein
-	I-Protein
dependent	I-Protein
kinase	I-Protein
-	I-Protein
1	E-Protein
,	O
and	O
the	O
YXXM	O
p85	S-Protein
binding	O
motif	O
of	O
several	O
proteins	O
and	O
redistribution	O
of	O
Akt	O
-	O
pleckstrin	O
homology	O
domain	O
-	O
green	O
fluorescent	O
protein	O
,	O
i	O
.	O
e	O
.	O
,	O
an	O
in	O
vivo	O
phosphatidylinositol	O
(	O
3	O
,	O
4	O
,	O
5	O
)	O
-	O
trisphosphate	O
sensor	O
,	O
from	O
membrane	O
to	O
cytosol	O
.	O

The	O
proapoptotic	O
effects	O
of	O
PAF	O
were	O
inhibited	O
by	O
both	O
n	O
-	O
3	O
and	O
n	O
-	O
6	O
polyunsaturated	O
fatty	O
acids	O
but	O
not	O
by	O
a	O
saturated	O
fatty	O
acid	O
palmitate	O
.	O

Indomethacin	O
,	O
an	O
inhibitor	O
of	O
prostaglandin	O
biosynthesis	O
,	O
did	O
not	O
influence	O
the	O
baseline	O
or	O
PAF	O
-	O
induced	O
apoptosis	O
,	O
but	O
2	O
-	O
bromopalmitate	O
,	O
an	O
inhibitor	O
of	O
protein	O
palmitoylation	O
,	O
inhibited	O
all	O
of	O
the	O
proapoptotic	O
effects	O
of	O
PAF	O
.	O

Our	O
data	O
strongly	O
suggest	O
that	O
an	O
inhibition	O
of	O
the	O
PI	O
3	O
-	O
kinase	O
/	O
Akt	O
signaling	O
pathway	O
is	O
the	O
main	O
mechanism	O
of	O
PAF	O
-	O
induced	O
apoptosis	O
in	O
enterocytes	O
and	O
that	O
polyunsaturated	O
fatty	O
acids	O
block	O
this	O
mechanism	O
very	O
early	O
in	O
the	O
signaling	O
cascade	O
independently	O
of	O
any	O
effect	O
on	O
prostaglandin	O
synthesis	O
,	O
and	O
probably	O
directly	O
via	O
an	O
effect	O
on	O
protein	O
palmitoylation	O
.	O

Ubiquitylation	O
is	O
required	O
for	O
degradation	O
of	O
transmembrane	O
surface	O
proteins	O
in	O
trypanosomes	O
.	O

The	O
surface	O
of	O
Trypanosoma	O
brucei	O
is	O
dominated	O
by	O
glycosyl	O
-	O
phosphatidylinositol	O
(	O
GPI	O
)	O
-	O
anchored	O
proteins	O
,	O
and	O
endocytosis	O
is	O
clathrin	O
dependent	O
.	O

The	O
vast	O
majority	O
of	O
internalized	O
GPI	O
-	O
anchored	O
protein	O
is	O
efficiently	O
recycled	O
,	O
while	O
the	O
processes	O
by	O
which	O
transmembrane	O
domain	O
(	O
TMD	O
)	O
proteins	O
are	O
internalized	O
and	O
sorted	O
are	O
unknown	O
.	O

We	O
demonstrate	O
that	O
internalization	O
of	O
invariant	B-Protein
surface	I-Protein
glycoprotein	I-Protein
(	I-Protein
ISG	I-Protein
)	I-Protein
65	E-Protein
,	O
a	O
trypanosome	O
TMD	O
protein	O
,	O
involves	O
ubiquitylation	O
and	O
also	O
requires	O
clathrin	O
.	O

We	O
find	O
a	O
hierarchical	O
requirement	O
for	O
cytoplasmic	O
lysine	O
residues	O
in	O
internalization	O
and	O
turnover	O
,	O
and	O
a	O
single	O
position	O
-	O
specific	O
lysine	O
is	O
sufficient	O
for	O
degradation	O
,	O
surface	O
removal	O
and	O
attachment	O
of	O
oligoubiquitin	S-Protein
chains	O
.	O

Ubiquitylation	O
is	O
context	O
dependent	O
as	O
provision	O
of	O
additional	O
lysine	O
residues	O
by	O
C	O
-	O
terminal	O
fusion	O
of	O
neuronal	B-Protein
precursor	I-Protein
cell	I-Protein
-	I-Protein
expressed	I-Protein
developmentally	I-Protein
downregulated	I-Protein
protein	I-Protein
(	I-Protein
NEDD	I-Protein
)	I-Protein
8	E-Protein
fails	O
to	O
support	O
ubiquitylation	O
.	O

Attachment	O
of	O
NEDD8	S-Protein
leads	O
to	O
degradation	O
by	O
a	O
second	O
ubiquitin	S-Protein
-	O
independent	O
pathway	O
.	O

Moreover	O
,	O
degradation	O
of	O
ubiquitylated	O
or	O
NEDDylated	O
substrate	O
takes	O
place	O
in	O
an	O
acidic	O
compartment	O
and	O
is	O
proteosome	O
independent	O
.	O

Significantly	O
,	O
in	O
non	O
-	O
opisthokont	O
lineages	O
,	O
Rsp5p	S-Protein
or	O
c	B-Protein
-	I-Protein
Cbl	E-Protein
,	O
the	O
E3	O
ubiquitin	S-Protein
ligases	O
acting	O
on	O
endocytic	O
cargo	O
,	O
are	O
absent	O
but	O
Uba1	S-Protein
class	O
genes	O
are	O
present	O
and	O
are	O
required	O
for	O
cell	O
viability	O
and	O
ISG65	S-Protein
ubiquitylation	O
.	O

Hence	O
,	O
ubiquitylation	O
is	O
an	O
evolutionarily	O
conserved	O
mechanism	O
for	O
internalization	O
of	O
surface	O
proteins	O
,	O
but	O
aspects	O
of	O
the	O
machinery	O
differ	O
substantially	O
between	O
the	O
major	O
eukaryotic	O
lineages	O
.	O

Innate	O
link	O
between	O
NF	O
-	O
kappaB	O
activity	O
and	O
ubiquitin	S-Protein
-	O
like	O
modifiers	O
.	O

Among	O
the	O
several	O
signalling	O
pathways	O
regulated	O
by	O
ubiquitin	S-Protein
and	O
ubiquitin	S-Protein
-	O
like	O
proteins	O
,	O
the	O
one	O
activating	O
NF	O
-	O
kappaB	O
(	O
nuclear	O
factor	O
kappaB	O
)	O
is	O
certainly	O
one	O
of	O
the	O
best	O
characterized	O
.	O

The	O
regulation	O
of	O
the	O
activity	O
of	O
this	O
transcription	O
factor	O
by	O
members	O
of	O
the	O
ubiquitin	S-Protein
family	O
occurs	O
at	O
various	O
levels	O
,	O
imposing	O
overlapping	O
controls	O
of	O
security	O
of	O
intriguing	O
complexity	O
.	O

The	O
formation	O
of	O
active	O
macromolecular	O
complexes	O
such	O
as	O
the	O
IKK	O
[	O
IkappaB	O
(	O
inhibitory	O
kappaB	O
)	O
kinase	O
]	O
complex	O
is	O
tightly	O
regulated	O
by	O
these	O
post	O
-	O
translational	O
modifications	O
probably	O
due	O
to	O
the	O
fact	O
that	O
many	O
signals	O
converge	O
on	O
this	O
signal	O
'	O
s	O
roundabout	O
.	O

An	O
additional	O
,	O
very	O
important	O
level	O
of	O
NF	O
-	O
kappaB	O
control	O
occurs	O
through	O
the	O
partial	O
or	O
total	O
proteolysis	O
of	O
precursor	O
and	O
inhibitor	O
molecules	O
exerted	O
by	O
the	O
ubiquitin	S-Protein
-	O
proteasome	O
pathway	O
.	O

Regulation	O
at	O
this	O
level	O
implicates	O
various	O
conjugating	O
and	O
de	O
-	O
conjugating	O
activities	O
for	O
ubiquitin	S-Protein
,	O
SUMO	O
(	O
small	O
ubiquitin	S-Protein
-	O
related	O
modifier	O
)	O
and	O
NEDD8	S-Protein
.	O

Here	O
,	O
we	O
summarize	O
some	O
of	O
these	O
events	O
and	O
underline	O
the	O
importance	O
of	O
the	O
interconnecting	O
ubiquitin	S-Protein
and	O
ubiquitin	S-Protein
-	O
like	O
conjugating	O
pathways	O
that	O
determine	O
the	O
status	O
of	O
the	O
activity	O
of	O
this	O
critical	O
transcription	O
factor	O
.	O

Identification	O
of	O
G	O
protein	O
alpha	O
subunit	O
-	O
palmitoylating	O
enzyme	O
.	O

The	O
heterotrimeric	O
G	O
protein	O
alpha	O
subunit	O
(	O
Galpha	O
)	O
is	O
targeted	O
to	O
the	O
cytoplasmic	O
face	O
of	O
the	O
plasma	O
membrane	O
through	O
reversible	O
lipid	O
palmitoylation	O
and	O
relays	O
signals	O
from	O
G	O
-	O
protein	O
-	O
coupled	O
receptors	O
(	O
GPCRs	O
)	O
to	O
its	O
effectors	O
.	O

By	O
screening	O
23	O
DHHC	O
motif	O
(	O
Asp	O
-	O
His	O
-	O
His	O
-	O
Cys	O
)	O
palmitoyl	O
acyl	O
-	O
transferases	O
,	O
we	O
identified	O
DHHC3	S-Protein
and	O
DHHC7	S-Protein
as	O
Galpha	O
palmitoylating	O
enzymes	O
.	O

DHHC3	S-Protein
and	O
DHHC7	S-Protein
robustly	O
palmitoylated	O
Galpha	B-Protein
(	I-Protein
q	I-Protein
)	E-Protein
,	O
Galpha	B-Protein
(	I-Protein
s	I-Protein
)	E-Protein
,	O
and	O
Galpha	B-Protein
(	I-Protein
i2	I-Protein
)	E-Protein
in	O
HEK293T	O
cells	O
.	O

Knockdown	O
of	O
DHHC3	S-Protein
and	O
DHHC7	S-Protein
decreased	O
Galpha	B-Protein
(	I-Protein
q	E-Protein
/	O
11	B-Protein
)	E-Protein
palmitoylation	O
and	O
relocalized	O
it	O
from	O
the	O
plasma	O
membrane	O
into	O
the	O
cytoplasm	O
.	O

Photoconversion	O
analysis	O
revealed	O
that	O
Galpha	B-Protein
(	I-Protein
q	I-Protein
)	E-Protein
rapidly	O
shuttles	O
between	O
the	O
plasma	O
membrane	O
and	O
the	O
Golgi	O
apparatus	O
,	O
where	O
DHHC3	S-Protein
specifically	O
localizes	O
.	O

Fluorescence	O
recovery	O
after	O
photobleaching	O
studies	O
showed	O
that	O
DHHC3	S-Protein
and	O
DHHC7	S-Protein
are	O
necessary	O
for	O
this	O
continuous	O
Galpha	B-Protein
(	I-Protein
q	I-Protein
)	E-Protein
shuttling	O
.	O

Furthermore	O
,	O
DHHC3	S-Protein
and	O
DHHC7	S-Protein
knockdown	O
blocked	O
the	O
alpha	B-Protein
(	I-Protein
1A	I-Protein
)	I-Protein
-	I-Protein
adrenergic	I-Protein
receptor	E-Protein
/	O
Galpha	B-Protein
(	I-Protein
q	E-Protein
/	O
11	B-Protein
)	E-Protein
-	O
mediated	O
signaling	O
pathway	O
.	O

Together	O
,	O
our	O
findings	O
revealed	O
that	O
DHHC3	S-Protein
and	O
DHHC7	S-Protein
regulate	O
GPCR	O
-	O
mediated	O
signal	O
transduction	O
by	O
controlling	O
Galpha	O
localization	O
to	O
the	O
plasma	O
membrane	O
.	O

Context	O
-	O
dependent	O
substrate	O
recognition	O
by	O
protein	O
farnesyltransferase	O
.	O

Prenylation	O
is	O
a	O
posttranslational	O
modification	O
whereby	O
C	O
-	O
terminal	O
lipidation	O
leads	O
to	O
protein	O
localization	O
to	O
membranes	O
.	O

A	O
C	O
-	O
terminal	O
"	O
Ca	O
(	O
1	O
)	O
a	O
(	O
2	O
)	O
X	O
"	O
sequence	O
has	O
been	O
proposed	O
as	O
the	O
recognition	O
motif	O
for	O
two	O
prenylation	O
enzymes	O
,	O
protein	O
farnesyltransferase	O
(	O
FTase	O
)	O
and	O
protein	O
geranylgeranyltransferase	O
type	O
I	O
.	O

To	O
define	O
the	O
parameters	O
involved	O
in	O
recognition	O
of	O
the	O
a	O
(	O
2	O
)	O
residue	O
,	O
we	O
performed	O
structure	O
-	O
activity	O
analysis	O
which	O
indicates	O
that	O
FTase	O
discriminates	O
between	O
peptide	O
substrates	O
based	O
on	O
both	O
the	O
hydrophobicity	O
and	O
steric	O
volume	O
of	O
the	O
side	O
chain	O
at	O
the	O
a	O
(	O
2	O
)	O
position	O
.	O

For	O
nonpolar	O
side	O
chains	O
,	O
the	O
dependence	O
of	O
the	O
reactivity	O
on	O
side	O
chain	O
volume	O
at	O
this	O
position	O
forms	O
a	O
pyramidal	O
pattern	O
with	O
a	O
maximal	O
activity	O
near	O
the	O
steric	O
volume	O
of	O
valine	O
.	O

This	O
discrimination	O
occurs	O
at	O
a	O
step	O
in	O
the	O
kinetic	O
mechanism	O
that	O
is	O
at	O
or	O
before	O
the	O
farnesylation	O
step	O
.	O

Furthermore	O
,	O
a	O
(	O
2	O
)	O
selectivity	O
is	O
also	O
affected	O
by	O
the	O
identity	O
of	O
the	O
adjacent	O
X	O
residue	O
,	O
leading	O
to	O
context	O
-	O
dependent	O
substrate	O
recognition	O
.	O

Context	O
-	O
dependent	O
a	O
(	O
2	O
)	O
selectivity	O
suggests	O
that	O
FTase	O
recognizes	O
the	O
sequence	O
downstream	O
of	O
the	O
conserved	O
cysteine	O
as	O
a	O
set	O
of	O
two	O
or	O
three	O
cooperative	O
,	O
interconnected	O
recognition	O
elements	O
as	O
opposed	O
to	O
three	O
independent	O
amino	O
acids	O
.	O

These	O
findings	O
expand	O
the	O
pool	O
of	O
proposed	O
FTase	O
substrates	O
in	O
cells	O
.	O

A	O
better	O
understanding	O
of	O
the	O
molecular	O
recognition	O
of	O
substrates	O
performed	O
by	O
FTase	O
will	O
aid	O
in	O
both	O
designing	O
new	O
FTase	O
inhibitors	O
as	O
therapeutic	O
agents	O
and	O
characterizing	O
proteins	O
involved	O
in	O
prenylation	O
-	O
dependent	O
cellular	O
pathways	O
.	O

Lysophosphatidic	B-Protein
acid	I-Protein
2	I-Protein
receptor	E-Protein
-	O
mediated	O
supramolecular	O
complex	O
formation	O
regulates	O
its	O
antiapoptotic	O
effect	O
.	O

The	O
G	O
protein	O
-	O
coupled	O
lysophosphatidic	B-Protein
acid	I-Protein
2	I-Protein
(	I-Protein
LPA	I-Protein
(	I-Protein
2	I-Protein
)	I-Protein
)	I-Protein
receptor	E-Protein
elicits	O
prosurvival	O
responses	O
to	O
prevent	O
and	O
rescue	O
cells	O
from	O
apoptosis	O
.	O

However	O
,	O
G	O
protein	O
-	O
coupled	O
signals	O
are	O
not	O
sufficient	O
for	O
the	O
full	O
protective	O
effect	O
of	O
LPA	B-Protein
(	I-Protein
2	I-Protein
)	E-Protein
.	O

LPA	B-Protein
(	I-Protein
2	I-Protein
)	E-Protein
differs	O
from	O
other	O
LPA	O
receptor	O
subtypes	O
in	O
the	O
C	O
-	O
terminal	O
tail	O
,	O
where	O
it	O
contains	O
a	O
zinc	O
finger	O
-	O
binding	O
motif	O
for	O
the	O
interactions	O
with	O
LIM	O
domain	O
-	O
containing	O
TRIP6	S-Protein
and	O
proapoptotic	O
Siva	B-Protein
-	I-Protein
1	E-Protein
,	O
and	O
a	O
PDZ	O
-	O
binding	O
motif	O
through	O
which	O
it	O
complexes	O
with	O
the	O
NHERF2	S-Protein
scaffold	O
protein	O
.	O

In	O
this	O
report	O
,	O
we	O
identify	O
a	O
unique	O
CXXC	O
motif	O
of	O
LPA	B-Protein
(	I-Protein
2	I-Protein
)	E-Protein
responsible	O
for	O
the	O
binding	O
to	O
TRIP6	S-Protein
and	O
Siva	B-Protein
-	I-Protein
1	E-Protein
,	O
and	O
demonstrate	O
that	O
disruption	O
of	O
these	O
macromolecular	O
complexes	O
or	O
knockdown	O
of	O
TRIP6	S-Protein
or	O
NHERF2	S-Protein
expression	O
attenuates	O
LPA	B-Protein
(	I-Protein
2	I-Protein
)	E-Protein
-	O
mediated	O
protection	O
from	O
chemotherapeutic	O
agent	O
-	O
induced	O
apoptosis	O
.	O

In	O
contrast	O
,	O
knockdown	O
of	O
Siva	B-Protein
-	I-Protein
1	E-Protein
expression	O
enhances	O
this	O
effect	O
.	O

Furthermore	O
,	O
a	O
PDZ	O
-	O
mediated	O
direct	O
interaction	O
between	O
TRIP6	S-Protein
and	O
NHERF2	S-Protein
facilitates	O
their	O
interaction	O
with	O
LPA	B-Protein
(	I-Protein
2	I-Protein
)	E-Protein
.	O

Together	O
,	O
these	O
results	O
suggest	O
that	O
in	O
addition	O
to	O
G	O
protein	O
-	O
activated	O
signals	O
,	O
the	O
cooperation	O
embedded	O
in	O
the	O
LPA	B-Protein
(	I-Protein
2	I-Protein
)	E-Protein
-	O
TRIP6	S-Protein
-	O
NHERF2	S-Protein
ternary	O
complex	O
provides	O
a	O
novel	O
ligand	O
-	O
dependent	O
signal	O
amplification	O
mechanism	O
that	O
is	O
required	O
for	O
LPA	B-Protein
(	I-Protein
2	I-Protein
)	E-Protein
-	O
mediated	O
full	O
activation	O
of	O
antiapoptotic	O
signaling	O
.	O

A	O
functional	O
screen	O
implicates	O
microRNA	B-Protein
-	I-Protein
138	E-Protein
-	O
dependent	O
regulation	O
of	O
the	O
depalmitoylation	O
enzyme	O
APT1	S-Protein
in	O
dendritic	O
spine	O
morphogenesis	O
.	O

The	O
microRNA	O
pathway	O
has	O
been	O
implicated	O
in	O
the	O
regulation	O
of	O
synaptic	O
protein	O
synthesis	O
and	O
ultimately	O
in	O
dendritic	O
spine	O
morphogenesis	O
,	O
a	O
phenomenon	O
associated	O
with	O
long	O
-	O
lasting	O
forms	O
of	O
memory	O
.	O

However	O
,	O
the	O
particular	O
microRNAs	O
(	O
miRNAs	O
)	O
involved	O
are	O
largely	O
unknown	O
.	O

Here	O
we	O
identify	O
specific	O
miRNAs	O
that	O
function	O
at	O
synapses	O
to	O
control	O
dendritic	O
spine	O
structure	O
by	O
performing	O
a	O
functional	O
screen	O
.	O

One	O
of	O
the	O
identified	O
miRNAs	O
,	O
miR	B-Protein
-	I-Protein
138	E-Protein
,	O
is	O
highly	O
enriched	O
in	O
the	O
brain	O
,	O
localized	O
within	O
dendrites	O
and	O
negatively	O
regulates	O
the	O
size	O
of	O
dendritic	O
spines	O
in	O
rat	O
hippocampal	O
neurons	O
.	O

miR	B-Protein
-	I-Protein
138	E-Protein
controls	O
the	O
expression	O
of	O
acyl	B-Protein
protein	I-Protein
thioesterase	I-Protein
1	E-Protein
(	O
APT1	S-Protein
)	O
,	O
an	O
enzyme	O
regulating	O
the	O
palmitoylation	O
status	O
of	O
proteins	O
that	O
are	O
known	O
to	O
function	O
at	O
the	O
synapse	O
,	O
including	O
the	O
alpha	O
(	O
13	O
)	O
subunits	O
of	O
G	O
proteins	O
(	O
Galpha	B-Protein
(	I-Protein
13	I-Protein
)	E-Protein
)	O
.	O

RNA	O
-	O
interference	O
-	O
mediated	O
knockdown	O
of	O
APT1	S-Protein
and	O
the	O
expression	O
of	O
membrane	O
-	O
localized	O
Galpha	B-Protein
(	I-Protein
13	I-Protein
)	E-Protein
both	O
suppress	O
spine	O
enlargement	O
caused	O
by	O
inhibition	O
of	O
miR	B-Protein
-	I-Protein
138	E-Protein
,	O
suggesting	O
that	O
APT1	S-Protein
-	O
regulated	O
depalmitoylation	O
of	O
Galpha	B-Protein
(	I-Protein
13	I-Protein
)	E-Protein
might	O
be	O
an	O
important	O
downstream	O
event	O
of	O
miR	B-Protein
-	I-Protein
138	E-Protein
function	O
.	O

Our	O
results	O
uncover	O
a	O
previously	O
unknown	O
miRNA	O
-	O
dependent	O
mechanism	O
in	O
neurons	O
and	O
demonstrate	O
a	O
previously	O
unrecognized	O
complexity	O
of	O
miRNA	O
-	O
dependent	O
control	O
of	O
dendritic	O
spine	O
morphogenesis	O
.	O

Four	O
flavonoids	O
from	O
Echinosophora	O
koreensis	O
and	O
their	O
effects	O
on	O
alcohol	O
metabolizing	O
enzymes	O
.	O

A	O
new	O
prenylated	O
dihydroflavonol	O
,	O
3	O
-	O
hydroxy	O
-	O
kenusanone	O
B	O
1	O
,	O
as	O
well	O
as	O
three	O
other	O
known	O
isoflavanones	O
,	O
sophoronol	O
2	O
,	O
sophoraisoflavanone	O
A	O
3	O
and	O
kenusanone	O
H	O
4	O
,	O
were	O
isolated	O
from	O
the	O
rhizomes	O
of	O
Echinosophora	O
koreensis	O
.	O

The	O
structures	O
of	O
these	O
compounds	O
were	O
elucidated	O
using	O
spectroscopic	O
analyses	O
that	O
included	O
extensive	O
2D	O
NMR	O
,	O
optical	O
rotation	O
spectrometry	O
and	O
mass	O
spectrometry	O
.	O

All	O
four	O
flavonoids	O
enhanced	O
the	O
activities	O
of	O
alcohol	O
metabolizing	O
enzymes	O
such	O
as	O
alcohol	O
dehydrogenase	O
(	O
ADH	O
)	O
and	O
aldehyde	O
dehydrogenase	O
(	O
ALDH	O
)	O
at	O
micromolar	O
concentrations	O
.	O

Sophoronol	O
2	O
showed	O
a	O
nine	O
-	O
fold	O
increased	O
activation	O
of	O
alcohol	O
dehydrogenase	O
and	O
aldehyde	O
dehydrogenase	O
than	O
a	O
negative	O
control	O
group	O
at	O
concentrations	O
of	O
100	O
microg	O
/	O
mL	O
and	O
50	O
microg	O
/	O
mL	O
,	O
respectively	O
.	O

This	O
study	O
suggests	O
that	O
prenylated	O
flavonoids	O
have	O
the	O
potential	O
to	O
prevent	O
'	O
hangovers	O
'	O
after	O
alcohol	O
intake	O
.	O

A	O
unique	O
lipoylation	O
system	O
in	O
the	O
Archaea	O
.	O

Lipoylation	O
in	O
Thermoplasma	O
acidophilum	O
requires	O
two	O
proteins	O
.	O

Members	O
of	O
the	O
2	O
-	O
oxoacid	O
dehydrogenase	O
multienzyme	O
complex	O
family	O
play	O
a	O
key	O
role	O
in	O
the	O
pathways	O
of	O
central	O
metabolism	O
.	O

Post	O
-	O
translational	O
lipoylation	O
of	O
the	O
dihydrolipoyl	O
acyltransferase	O
component	O
of	O
these	O
complexes	O
is	O
essential	O
for	O
their	O
activity	O
,	O
the	O
lipoyllysine	O
moiety	O
performing	O
the	O
transfer	O
of	O
substrates	O
and	O
intermediates	O
between	O
the	O
different	O
active	O
sites	O
within	O
these	O
multienzyme	O
systems	O
.	O

We	O
have	O
previously	O
shown	O
that	O
the	O
thermophilic	O
archaeon	O
,	O
Thermoplasma	O
acidophilum	O
,	O
has	O
a	O
four	O
-	O
gene	O
cluster	O
encoding	O
the	O
components	O
of	O
such	O
a	O
complex	O
,	O
which	O
,	O
when	O
recombinantly	O
expressed	O
in	O
Escherichia	O
coli	O
,	O
can	O
be	O
assembled	O
into	O
an	O
active	O
multienzyme	O
in	O
vitro	O
.	O

Crucially	O
,	O
the	O
E	O
.	O
coli	O
host	O
carries	O
out	O
the	O
required	O
lipoylation	O
of	O
the	O
archaeal	O
dihydrolipoyl	O
acyltransferase	O
component	O
.	O

Because	O
active	O
2	O
-	O
oxoacid	O
dehydrogenase	O
multienzyme	O
complexes	O
have	O
never	O
been	O
detected	O
in	O
any	O
archaeon	O
,	O
the	O
question	O
arises	O
as	O
to	O
whether	O
Archaea	O
possess	O
a	O
functional	O
lipoylation	O
system	O
.	O

In	O
this	O
study	O
,	O
we	O
report	O
the	O
cloning	O
and	O
heterologous	O
expression	O
of	O
two	O
genes	O
from	O
Tp	O
.	O
acidophilum	O
whose	O
protein	O
products	O
together	O
show	O
significant	O
sequence	O
identity	O
with	O
the	O
single	O
lipoate	O
protein	O
ligase	O
enzyme	O
of	O
bacteria	O
.	O

We	O
demonstrate	O
that	O
both	O
recombinantly	O
expressed	O
Tp	O
.	O
acidophilum	O
proteins	O
are	O
required	O
for	O
lipoylation	O
of	O
the	O
acyltransferase	O
,	O
and	O
that	O
the	O
two	O
proteins	O
associate	O
together	O
to	O
carry	O
out	O
this	O
post	O
-	O
translational	O
modification	O
.	O

From	O
the	O
published	O
DNA	O
sequences	O
,	O
we	O
suggest	O
the	O
presence	O
of	O
functional	O
transcriptional	O
and	O
translational	O
regulatory	O
elements	O
,	O
and	O
furthermore	O
we	O
present	O
preliminary	O
evidence	O
that	O
lipoylation	O
occurs	O
in	O
vivo	O
in	O
Tp	O
.	O
acidophilum	O
.	O

This	O
is	O
the	O
first	O
report	O
of	O
the	O
lipoylation	O
machinery	O
in	O
the	O
Archaea	O
,	O
which	O
is	O
unique	O
in	O
that	O
the	O
catalytic	O
activity	O
is	O
dependent	O
on	O
two	O
separate	O
gene	O
products	O
.	O

Molecular	O
basis	O
of	O
canonical	O
and	O
bactericidal	O
autophagy	O
.	O

Autophagy	O
is	O
a	O
catabolic	O
process	O
by	O
which	O
cells	O
degrade	O
their	O
own	O
cytoplasmic	O
constituents	O
.	O

Cells	O
respond	O
to	O
the	O
stress	O
response	O
of	O
nutrient	O
deficiency	O
by	O
degrading	O
a	O
portion	O
of	O
their	O
cellular	O
components	O
to	O
produce	O
amino	O
acids	O
and	O
energy	O
.	O

Recently	O
,	O
it	O
became	O
evident	O
that	O
the	O
autophagic	O
machinery	O
is	O
also	O
involved	O
in	O
a	O
kind	O
of	O
innate	O
immune	O
system	O
.	O

Some	O
bacteria	O
that	O
invade	O
mammalian	O
cells	O
are	O
eventually	O
entrapped	O
in	O
an	O
autophagic	O
membrane	O
structure	O
.	O

In	O
this	O
review	O
,	O
we	O
describe	O
the	O
current	O
understanding	O
of	O
three	O
of	O
the	O
basic	O
components	O
of	O
the	O
canonical	O
autophagy	O
machinery	O
-	O
LC3	O
,	O
the	O
Atg16L	O
complex	O
and	O
phosphatidylinositol	O
3	O
-	O
phosphate	O
(	O
PI3P	O
)	O
-	O
which	O
are	O
dynamically	O
associated	O
with	O
the	O
autophagic	O
structure	O
.	O

LC3	O
is	O
proposed	O
to	O
function	O
in	O
autophagosome	O
closure	O
,	O
whereas	O
the	O
Atg16L	O
complex	O
functions	O
as	O
an	O
E3	O
-	O
like	O
protein	O
in	O
ubiquitination	O
-	O
like	O
reactions	O
in	O
the	O
LC3	O
lipidation	O
system	O
.	O

PI3P	O
is	O
a	O
key	O
determinant	O
of	O
the	O
autophagic	O
membrane	O
.	O

Further	O
,	O
their	O
relation	O
to	O
bactericidal	O
autophagy	O
(	O
i	O
.	O
e	O
.	O
xenophagy	O
)	O
will	O
be	O
introduced	O
.	O

Three	O
-	O
dimensional	O
organization	O
of	O
promyelocytic	O
leukemia	O
nuclear	O
bodies	O
.	O

Promyelocytic	O
leukemia	O
nuclear	O
bodies	O
(	O
PML	O
-	O
NBs	O
)	O
are	O
mobile	O
subnuclear	O
organelles	O
formed	O
by	O
PML	S-Protein
and	O
Sp100	S-Protein
protein	O
.	O

They	O
have	O
been	O
reported	O
to	O
have	O
a	O
role	O
in	O
transcription	O
,	O
DNA	O
replication	O
and	O
repair	O
,	O
telomere	O
lengthening	O
,	O
cell	O
cycle	O
control	O
and	O
tumor	O
suppression	O
.	O

We	O
have	O
conducted	O
high	O
-	O
resolution	O
4Pi	O
fluorescence	O
laser	O
-	O
scanning	O
microscopy	O
studies	O
complemented	O
with	O
correlative	O
electron	O
microscopy	O
and	O
investigations	O
of	O
the	O
accessibility	O
of	O
the	O
PML	O
-	O
NB	O
subcompartment	O
.	O

During	O
interphase	O
PML	O
-	O
NBs	O
adopt	O
a	O
spherical	O
organization	O
characterized	O
by	O
the	O
assembly	O
of	O
PML	S-Protein
and	O
Sp100	S-Protein
proteins	O
into	O
patches	O
within	O
a	O
50	O
-	O
to	O
100	O
-	O
nm	O
-	O
thick	O
shell	O
.	O

This	O
spherical	O
shell	O
of	O
PML	S-Protein
and	O
Sp100	S-Protein
imposes	O
little	O
constraint	O
to	O
the	O
exchange	O
of	O
components	O
between	O
the	O
PML	O
-	O
NB	O
interior	O
and	O
the	O
nucleoplasm	O
.	O

Post	O
-	O
translational	O
SUMO	O
modifications	O
,	O
telomere	O
repeats	O
and	O
heterochromatin	B-Protein
protein	I-Protein
1	E-Protein
were	O
found	O
to	O
localize	O
in	O
characteristic	O
patterns	O
with	O
respect	O
to	O
PML	S-Protein
and	O
Sp100	S-Protein
.	O

From	O
our	O
findings	O
,	O
we	O
derived	O
a	O
model	O
that	O
explains	O
how	O
the	O
three	O
-	O
dimensional	O
organization	O
of	O
PML	O
-	O
NBs	O
serves	O
to	O
concentrate	O
different	O
biological	O
activities	O
while	O
allowing	O
for	O
an	O
efficient	O
exchange	O
of	O
components	O
.	O

The	O
structure	O
of	O
dopamine	O
induced	O
alpha	B-Protein
-	I-Protein
synuclein	E-Protein
oligomers	O
.	O

Inclusions	O
of	O
aggregated	O
alpha	B-Protein
-	I-Protein
synuclein	E-Protein
(	O
alpha	B-Protein
-	I-Protein
syn	E-Protein
)	O
in	O
dopaminergic	O
neurons	O
are	O
a	O
characteristic	O
histological	O
marker	O
of	O
Parkinson	O
'	O
s	O
disease	O
(	O
PD	O
)	O
.	O

In	O
vitro	O
,	O
alpha	B-Protein
-	I-Protein
syn	E-Protein
in	O
the	O
presence	O
of	O
dopamine	O
(	O
DA	O
)	O
at	O
physiological	O
pH	O
forms	O
SDS	O
-	O
resistant	O
non	O
-	O
amyloidogenic	O
oligomers	O
.	O

We	O
used	O
a	O
combination	O
of	O
biophysical	O
techniques	O
,	O
including	O
sedimentation	O
velocity	O
analysis	O
,	O
small	O
angle	O
X	O
-	O
ray	O
scattering	O
(	O
SAXS	O
)	O
and	O
circular	O
dichroism	O
spectroscopy	O
to	O
study	O
the	O
characteristics	O
of	O
alpha	B-Protein
-	I-Protein
syn	E-Protein
oligomers	O
formed	O
in	O
the	O
presence	O
of	O
DA	O
.	O

Our	O
SAXS	O
data	O
show	O
that	O
the	O
trimers	O
formed	O
by	O
the	O
action	O
of	O
DA	O
on	O
alpha	B-Protein
-	I-Protein
syn	E-Protein
consist	O
of	O
overlapping	O
worm	O
-	O
like	O
monomers	O
,	O
with	O
no	O
end	O
-	O
to	O
-	O
end	O
associations	O
.	O

This	O
lack	O
of	O
structure	O
contrasts	O
with	O
the	O
well	O
-	O
established	O
,	O
extensive	O
beta	O
-	O
sheet	O
structure	O
of	O
the	O
amyloid	S-Protein
fibril	O
form	O
of	O
the	O
protein	O
and	O
its	O
pre	O
-	O
fibrillar	O
oligomers	O
.	O

We	O
propose	O
on	O
the	O
basis	O
of	O
these	O
and	O
earlier	O
data	O
that	O
oxidation	O
of	O
the	O
four	O
methionine	O
residues	O
at	O
the	O
C	O
-	O
and	O
N	O
-	O
terminal	O
ends	O
of	O
alpha	B-Protein
-	I-Protein
syn	E-Protein
molecules	O
prevents	O
their	O
end	O
-	O
to	O
-	O
end	O
association	O
and	O
stabilises	O
oligomers	O
formed	O
by	O
cross	O
linking	O
with	O
DA	O
-	O
quinone	O
/	O
DA	O
-	O
melanin	O
,	O
which	O
are	O
formed	O
as	O
a	O
result	O
of	O
the	O
redox	O
process	O
,	O
thus	O
inhibiting	O
formation	O
of	O
the	O
beta	O
-	O
sheet	O
structure	O
found	O
in	O
other	O
pre	O
-	O
fibrillar	O
forms	O
of	O
alpha	B-Protein
-	I-Protein
syn	E-Protein
.	O

NEDD8	S-Protein
-	O
targeting	O
drug	O
MLN4924	O
elicits	O
DNA	O
rereplication	O
by	O
stabilizing	O
Cdt1	S-Protein
in	O
S	O
phase	O
,	O
triggering	O
checkpoint	O
activation	O
,	O
apoptosis	O
,	O
and	O
senescence	O
in	O
cancer	O
cells	O
.	O

MLN4924	O
is	O
a	O
first	O
-	O
in	O
-	O
class	O
experimental	O
cancer	O
drug	O
that	O
inhibits	O
the	O
NEDD8	S-Protein
-	O
activating	O
enzyme	O
,	O
thereby	O
inhibiting	O
cullin	O
-	O
RING	O
E3	O
ubiquitin	S-Protein
ligases	O
and	O
stabilizing	O
many	O
cullin	O
substrates	O
.	O

The	O
mechanism	O
by	O
which	O
MLN4924	O
inhibits	O
cancer	O
cell	O
proliferation	O
has	O
not	O
been	O
defined	O
,	O
although	O
it	O
is	O
accompanied	O
by	O
DNA	O
rereplication	O
and	O
attendant	O
DNA	O
damage	O
.	O

Here	O
we	O
show	O
that	O
stabilization	O
of	O
the	O
DNA	O
replication	O
factor	O
Cdt1	S-Protein
,	O
a	O
substrate	O
of	O
cullins	B-Protein
1	E-Protein
and	O
4	S-Protein
,	O
is	O
critical	O
for	O
MLN4924	O
to	O
trigger	O
DNA	O
rereplication	O
and	O
inhibit	O
cell	O
proliferation	O
.	O

Even	O
only	O
1	O
hour	O
of	O
exposure	O
to	O
MLN4924	O
,	O
which	O
was	O
sufficient	O
to	O
elevate	O
Cdt1	S-Protein
for	O
4	O
-	O
5	O
hours	O
,	O
was	O
found	O
to	O
be	O
sufficient	O
to	O
induce	O
DNA	O
rereplication	O
and	O
to	O
activate	O
apoptosis	O
and	O
senescence	O
pathways	O
.	O

Cells	O
in	O
S	O
phase	O
were	O
most	O
susceptible	O
,	O
suggesting	O
that	O
MLN4924	O
will	O
be	O
most	O
toxic	O
on	O
highly	O
proliferating	O
cancers	O
.	O

Although	O
MLN4924	O
-	O
induced	O
cell	O
senescence	O
seems	O
to	O
be	O
dependent	O
on	O
induction	O
of	O
p53	S-Protein
and	O
its	O
downstream	O
effector	O
p21	S-Protein
(	O
Waf1	S-Protein
)	O
,	O
we	O
found	O
that	O
p53	S-Protein
(	O
-	O
/	O
-	O
)	O
and	O
p21	S-Protein
(	O
-	O
/	O
-	O
)	O
cells	O
were	O
even	O
more	O
susceptible	O
than	O
wild	O
-	O
type	O
cells	O
to	O
MLN4924	O
.	O

Our	O
results	O
suggested	O
that	O
apoptosis	O
,	O
not	O
senescence	O
,	O
might	O
be	O
more	O
important	O
for	O
the	O
antiproliferative	O
effect	O
of	O
MLN4924	O
.	O

Furthermore	O
,	O
our	O
findings	O
show	O
that	O
transient	O
exposure	O
to	O
this	O
new	O
investigational	O
drug	O
should	O
be	O
useful	O
for	O
controlling	O
p53	S-Protein
-	O
negative	O
cancer	O
cells	O
,	O
which	O
often	O
pose	O
significant	O
clinical	O
challenge	O
.	O

Mechanisms	O
of	O
metal	O
ion	O
incorporation	O
into	O
metalloproteins	O
.	O

Although	O
the	O
structure	O
and	O
function	O
of	O
protein	O
metallocenters	O
have	O
been	O
extensively	O
characterized	O
,	O
much	O
less	O
is	O
known	O
about	O
their	O
assembly	O
.	O

Here	O
,	O
I	O
describe	O
several	O
general	O
strategies	O
for	O
metallocenter	O
biosynthesis	O
and	O
provide	O
literature	O
precedents	O
for	O
each	O
mechanism	O
.	O

The	O
simplest	O
mechanism	O
involves	O
reversible	O
metal	O
ion	O
binding	O
to	O
amino	O
acid	O
ligands	O
of	O
the	O
apo	O
-	O
protein	O
.	O

In	O
a	O
variation	O
of	O
this	O
mechanism	O
,	O
the	O
apo	O
-	O
protein	O
first	O
must	O
be	O
phosphorylated	O
,	O
carboxylated	O
or	O
otherwise	O
covalently	O
modified	O
in	O
order	O
to	O
create	O
the	O
metal	O
ion	O
binding	O
site	O
.	O

Alternatively	O
,	O
passive	O
metal	O
ion	O
binding	O
may	O
require	O
the	O
presence	O
of	O
an	O
associated	O
compound	O
,	O
such	O
as	O
a	O
nucleotide	O
,	O
carbonate	O
or	O
inorganic	O
sulfide	O
,	O
which	O
is	O
co	O
-	O
incorporated	O
into	O
the	O
protein	O
along	O
with	O
the	O
metal	O
ion	O
.	O

In	O
addition	O
,	O
reversible	O
binding	O
may	O
occur	O
using	O
a	O
pre	O
-	O
formed	O
organometallic	O
cofactor	O
such	O
as	O
a	O
metal	O
-	O
tetrapyrrole	O
.	O

Electron	O
transfer	O
reactions	O
are	O
coupled	O
to	O
biosynthesis	O
of	O
certain	O
metallocenters	O
,	O
i	O
.	O
e	O
.	O
oxidation	O
or	O
reduction	O
of	O
the	O
metallocenter	O
or	O
apo	O
-	O
protein	O
may	O
be	O
required	O
prior	O
to	O
binding	O
,	O
or	O
once	O
bound	O
the	O
metallocenter	O
may	O
be	O
oxidatively	O
trapped	O
in	O
the	O
protein	O
.	O

An	O
effector	O
molecule	O
may	O
bind	O
to	O
apo	O
-	O
protein	O
to	O
open	O
up	O
or	O
stabilize	O
the	O
metallocenter	O
binding	O
site	O
,	O
then	O
after	O
the	O
metallocenter	O
is	O
incorporated	O
the	O
effector	O
molecule	O
dissociates	O
.	O

A	O
transferase	O
or	O
insertase	O
protein	O
first	O
may	O
bind	O
the	O
metallocenter	O
and	O
then	O
incorporate	O
it	O
into	O
the	O
appropriate	O
apo	O
-	O
protein	O
.	O

Finally	O
,	O
metal	O
cofactors	O
may	O
be	O
covalently	O
attached	O
to	O
proteins	O
.	O

Regardless	O
of	O
the	O
metallocenter	O
biosynthetic	O
mechanism	O
,	O
intracellular	O
metal	O
ion	O
concentrations	O
must	O
be	O
sufficient	O
;	O
hence	O
,	O
metal	O
ion	O
transport	O
systems	O
also	O
are	O
briefly	O
discussed	O
.	O

The	O
effect	O
of	O
sulfation	O
on	O
the	O
anticoagulant	O
and	O
antithrombin	B-Protein
III	E-Protein
-	O
binding	O
properties	O
of	O
a	O
heparin	O
fraction	O
with	O
low	O
affinity	O
for	O
antithrombin	B-Protein
III	E-Protein
.	O

Heparin	O
with	O
low	O
affinity	O
for	O
antithrombin	B-Protein
III	E-Protein
(	O
ATIII	S-Protein
)	O
and	O
devoid	O
of	O
anticoagulant	O
activity	O
was	O
chemically	O
oversulfated	O
and	O
fractionated	O
by	O
affinity	O
for	O
ATIII	S-Protein
.	O

The	O
oversulfated	O
material	O
showed	O
ATIII	S-Protein
binding	O
properties	O
,	O
as	O
monitored	O
by	O
intrinsic	O
fluorescence	O
enhancement	O
of	O
ATIII	S-Protein
.	O

The	O
fluorescence	O
increase	O
was	O
comparable	O
to	O
that	O
of	O
the	O
AT	B-Protein
III	E-Protein
high	O
affinity	O
fraction	O
of	O
native	O
heparin	O
.	O

The	O
estimated	O
dissociation	O
constants	O
however	O
,	O
showed	O
a	O
10	O
-	O
fold	O
weaker	O
binding	O
of	O
the	O
oversulfated	O
material	O
to	O
ATIII	S-Protein
,	O
Kd	O
=	O
6	O
.	O
4	O
x	O
10	O
(	O
-	O
8	O
)	O
M	O
,	O
as	O
compared	O
to	O
native	O
heparin	O
,	O
Kd	O
=	O
0	O
.	O
63	O
x	O
10	O
(	O
-	O
8	O
)	O
M	O
.	O

Concomitant	O
with	O
the	O
binding	O
-	O
induced	O
allosteric	O
change	O
in	O
ATIII	S-Protein
,	O
the	O
oversulfated	O
material	O
stimulated	O
the	O
ATIII	S-Protein
-	O
thrombin	S-Protein
and	O
ATIII	S-Protein
-	O
factor	B-Protein
Xa	E-Protein
reactions	O
.	O

The	O
high	O
affinity	O
fractions	O
of	O
native	O
heparin	O
and	O
the	O
sulfated	O
material	O
were	O
almost	O
equally	O
effective	O
in	O
enhancing	O
the	O
rate	O
of	O
thrombin	S-Protein
neutralization	O
by	O
ATIII	S-Protein
.	O

However	O
,	O
a	O
3	O
-	O
fold	O
faster	O
rate	O
of	O
factor	B-Protein
Xa	E-Protein
inactivation	O
was	O
found	O
with	O
the	O
native	O
high	O
affinity	O
material	O
.	O

Acylation	O
and	O
carbamylation	O
of	O
equine	O
muscle	O
carbonic	O
anhydrase	O
(	O
CA	B-Protein
-	I-Protein
III	E-Protein
)	O
upon	O
reaction	O
with	O
p	O
-	O
nitrophenyl	O
esters	O
and	O
carbamoyl	O
phosphate	O
.	O

Equine	O
muscle	O
carbonic	O
anhydrase	O
(	O
CA	B-Protein
-	I-Protein
III	E-Protein
)	O
behaves	O
like	O
ubiquitin	O
in	O
undergoing	O
extensive	O
acylation	O
of	O
N	O
epsilon	O
-	O
lysine	O
residues	O
upon	O
reacting	O
with	O
p	O
-	O
nitrophenyl	O
esters	O
.	O

The	O
enzyme	O
undergoes	O
extensive	O
carbamoylation	O
of	O
lysine	O
residues	O
when	O
reacted	O
with	O
carbamoyl	O
phosphate	O
.	O

The	O
modification	O
of	O
from	O
6	O
to	O
7	O
lysine	O
residues	O
results	O
in	O
the	O
production	O
of	O
a	O
series	O
of	O
more	O
anodic	O
electrophoretic	O
components	O
.	O

The	O
derivatization	O
of	O
the	O
lysine	O
residues	O
leads	O
to	O
a	O
marked	O
decrease	O
in	O
the	O
enzyme	O
'	O
s	O
ability	O
to	O
hydrate	O
CO2	O
.	O

The	O
equine	O
CA	B-Protein
-	I-Protein
III	E-Protein
possesses	O
both	O
acid	O
and	O
alkaline	O
phosphatase	O
activities	O
in	O
contrast	O
to	O
the	O
rabbit	O
which	O
possesses	O
only	O
the	O
former	O
type	O
.	O

Posttranslational	O
processing	O
of	O
human	O
alpha	B-Protein
2	I-Protein
-	I-Protein
HS	I-Protein
glycoprotein	E-Protein
(	O
human	O
fetuin	O
)	O
.	O

Evidence	O
for	O
the	O
production	O
of	O
a	O
phosphorylated	O
single	O
-	O
chain	O
form	O
by	O
hepatoma	O
cells	O
.	O

alpha	B-Protein
2	I-Protein
-	I-Protein
HS	I-Protein
glycoprotein	E-Protein
(	O
alpha	B-Protein
2	I-Protein
-	I-Protein
HS	E-Protein
)	O
is	O
a	O
major	O
protein	O
occurring	O
in	O
human	O
blood	O
and	O
calciferous	O
tissues	O
.	O

Due	O
to	O
extensive	O
sequence	O
identity	O
,	O
alpha	B-Protein
2	I-Protein
-	I-Protein
HS	E-Protein
has	O
been	O
grouped	O
with	O
the	O
fetuins	O
,	O
a	O
family	O
of	O
proteins	O
that	O
occur	O
in	O
fetal	O
plasma	O
in	O
high	O
concentrations	O
.	O

Native	O
alpha	B-Protein
2	I-Protein
-	I-Protein
HS	E-Protein
undergoes	O
a	O
series	O
of	O
posttranslational	O
modifications	O
including	O
proteolytic	O
processing	O
,	O
multiple	O
N	O
-	O
glycosylations	O
and	O
O	O
-	O
glycosylations	O
,	O
and	O
sulfation	O
of	O
the	O
carbohydrate	O
side	O
chains	O
.	O

Various	O
two	O
-	O
chain	O
forms	O
of	O
alpha	O
2	O
-	O
HS	O
have	O
been	O
prepared	O
from	O
human	O
plasma	O
,	O
however	O
,	O
the	O
single	O
-	O
chain	O
precursor	O
has	O
not	O
yet	O
been	O
isolated	O
.	O

Here	O
,	O
we	O
have	O
studied	O
the	O
biosynthesis	O
of	O
alpha	B-Protein
2	I-Protein
-	I-Protein
HS	E-Protein
by	O
a	O
human	O
hepatoma	O
cell	O
line	O
,	O
HepG2	O
.	O

We	O
demonstrate	O
that	O
a	O
single	O
-	O
chain	O
form	O
and	O
the	O
two	O
-	O
chain	O
form	O
of	O
alpha	B-Protein
2	I-Protein
-	I-Protein
HS	E-Protein
are	O
secreted	O
by	O
this	O
cell	O
line	O
.	O

The	O
alpha	B-Protein
2	I-Protein
-	I-Protein
HS	E-Protein
forms	O
are	O
further	O
modified	O
by	O
phosphorylation	O
on	O
multiple	O
serine	O
residues	O
.	O

Mapping	O
studies	O
indicate	O
that	O
the	O
connecting	O
peptide	O
region	O
releasable	O
from	O
the	O
heavy	O
chain	O
of	O
alpha	B-Protein
2	I-Protein
-	I-Protein
HS	E-Protein
contains	O
at	O
least	O
one	O
such	O
phosphorylation	O
site	O
.	O

Our	O
results	O
identify	O
proteolytic	O
trimming	O
and	O
/	O
or	O
phosphorylation	O
as	O
modifications	O
possibly	O
regulating	O
the	O
biological	O
effects	O
of	O
alpha	B-Protein
2	I-Protein
-	I-Protein
HS	E-Protein
and	O
the	O
homologous	O
fetuins	O
.	O

P	B-Protein
-	I-Protein
selectin	E-Protein
is	O
acylated	O
with	O
palmitic	O
acid	O
and	O
stearic	O
acid	O
at	O
cysteine	O
766	O
through	O
a	O
thioester	O
linkage	O
.	O

We	O
report	O
that	O
the	O
adhesion	O
receptor	O
P	B-Protein
-	I-Protein
selectin	E-Protein
can	O
be	O
metabolically	O
labeled	O
with	O
[	O
3H	O
]	O
palmitic	O
acid	O
in	O
human	O
platelets	O
.	O

Analysis	O
of	O
alkaline	O
methanolysis	O
products	O
from	O
labeled	O
protein	O
demonstrated	O
that	O
the	O
radioactivity	O
associated	O
with	O
P	B-Protein
-	I-Protein
selectin	E-Protein
was	O
covalently	O
bound	O
palmitic	O
acid	O
.	O

[	O
3H	O
]	O
Palmitic	O
acid	O
was	O
cleaved	O
by	O
hydroxylamine	O
treatment	O
at	O
neutral	O
pH	O
and	O
by	O
reducing	O
agents	O
,	O
indicating	O
that	O
acylation	O
occurred	O
through	O
a	O
thioester	O
linkage	O
.	O

Both	O
stearic	O
acid	O
and	O
palmitic	O
acid	O
were	O
detected	O
by	O
gas	O
chromatography	O
-	O
mass	O
spectrometry	O
analysis	O
of	O
alkaline	O
hydrolysates	O
of	O
purified	O
P	B-Protein
-	I-Protein
selectin	E-Protein
.	O

Deletion	O
or	O
mutation	O
of	O
Cys766	O
eliminated	O
[	O
3H	O
]	O
palmitic	O
acid	O
labeling	O
of	O
P	B-Protein
-	I-Protein
selectin	E-Protein
in	O
transfected	O
COS	O
-	O
7	O
cells	O
.	O

We	O
conclude	O
that	O
the	O
cytoplasmic	O
domain	O
of	O
P	B-Protein
-	I-Protein
selectin	E-Protein
is	O
acylated	O
at	O
Cys766	O
through	O
a	O
thioester	O
bond	O
.	O

Fatty	O
acid	O
acylation	O
may	O
regulate	O
intracellular	O
trafficking	O
or	O
other	O
functions	O
of	O
P	B-Protein
-	I-Protein
selectin	E-Protein
.	O

ADP	O
ribosylation	O
factor	O
and	O
a	O
14	O
-	O
kD	O
polypeptide	O
are	O
associated	O
with	O
heparan	O
sulfate	O
-	O
carrying	O
post	O
-	O
trans	O
-	O
Golgi	O
network	O
secretory	O
vesicles	O
in	O
rat	O
hepatocytes	O
.	O

Constitutive	O
secretory	O
vesicles	O
carrying	O
heparan	B-Protein
sulfate	I-Protein
proteoglycan	E-Protein
(	O
HSPG	S-Protein
)	O
were	O
identified	O
in	O
isolated	O
rat	O
hepatocytes	O
by	O
pulse	O
-	O
chase	O
experiments	O
with	O
[	O
35S	O
]	O
sulfate	O
and	O
purified	O
by	O
velocity	O
-	O
controlled	O
sucrose	O
gradient	O
centrifugation	O
followed	O
by	O
equilibrium	O
density	O
centrifugation	O
in	O
Nycodenz	O
.	O

Using	O
this	O
procedure	O
,	O
the	O
vesicles	O
were	O
separated	O
from	O
plasma	O
membranes	O
,	O
Golgi	O
,	O
trans	O
-	O
Golgi	O
network	O
(	O
TGN	O
)	O
,	O
ER	O
,	O
endosomes	O
,	O
lysosomes	O
,	O
transcytotic	O
vesicles	O
,	O
and	O
mitochondria	O
.	O

The	O
diameter	O
of	O
these	O
vesicles	O
was	O
approximately	O
100	O
-	O
200	O
nm	O
as	O
determined	O
by	O
electron	O
microscopy	O
.	O

A	O
typical	O
coat	O
structure	O
as	O
described	O
for	O
intra	O
-	O
Golgi	O
transport	O
vesicles	O
or	O
clathrin	O
-	O
coated	O
vesicles	O
could	O
not	O
be	O
seen	O
,	O
and	O
the	O
vesicles	O
were	O
not	O
associated	O
with	O
the	O
coat	O
protein	O
beta	B-Protein
-	I-Protein
COP	E-Protein
.	O

Furthermore	O
,	O
the	O
vesicles	O
appear	O
to	O
represent	O
a	O
low	O
density	O
compartment	O
(	O
1	O
.	O
05	O
-	O
1	O
.	O
06	O
g	O
/	O
ml	O
)	O
.	O

Other	O
constitutively	O
secreted	O
proteins	O
(	O
rat	O
serum	B-Protein
albumin	E-Protein
,	O
apolipoprotein	B-Protein
E	E-Protein
,	O
and	O
fibrinogen	O
)	O
could	O
not	O
be	O
detected	O
in	O
purified	O
HSPG	S-Protein
-	O
carrying	O
vesicles	O
,	O
but	O
banded	O
in	O
the	O
denser	O
fractions	O
of	O
the	O
Nycodenz	O
gradient	O
.	O

Moreover	O
,	O
during	O
pulse	O
-	O
chase	O
labeling	O
with	O
[	O
35S	O
]	O
methionine	O
,	O
labeled	O
albumin	S-Protein
did	O
not	O
appear	O
in	O
the	O
post	O
-	O
TGN	O
vesicle	O
fraction	O
carrying	O
HSPGs	S-Protein
.	O

These	O
findings	O
indicate	O
sorting	O
of	O
HSPGs	S-Protein
and	O
albumin	S-Protein
into	O
different	O
types	O
of	O
constitutive	O
secretory	O
vesicles	O
in	O
hepatocytes	O
.	O

Two	O
proteins	O
were	O
found	O
to	O
be	O
tightly	O
associated	O
with	O
the	O
membranes	O
of	O
the	O
HSPG	S-Protein
carrying	O
vesicles	O
:	O
a	O
member	O
of	O
the	O
ADP	O
ribosylation	O
factor	O
family	O
of	O
small	O
guanine	O
nucleotide	O
-	O
binding	O
proteins	O
and	O
an	O
unknown	O
14	O
-	O
kD	O
peripheral	O
membrane	O
protein	O
(	O
VAPP14	O
)	O
.	O

Concerning	O
the	O
secretory	O
pathway	O
,	O
we	O
conclude	O
from	O
these	O
results	O
that	O
ADP	O
ribosylation	O
factor	O
proteins	O
are	O
not	O
only	O
involved	O
in	O
vesicular	O
transport	O
from	O
the	O
ER	O
via	O
the	O
Golgi	O
to	O
the	O
TGN	O
,	O
but	O
also	O
in	O
vesicular	O
transport	O
from	O
the	O
TGN	O
to	O
the	O
plasma	O
membrane	O
.	O

Tyrosine	O
sulfation	O
of	O
varicella	O
-	O
zoster	O
virus	O
envelope	O
glycoprotein	O
gpl	S-Protein
.	O

Sulfation	O
is	O
a	O
common	O
post	O
-	O
translational	O
modification	O
of	O
secreted	O
and	O
membrane	O
proteins	O
,	O
with	O
the	O
sulfate	O
attached	O
to	O
tyrosine	O
residues	O
or	O
to	O
glycan	O
side	O
-	O
chains	O
.	O

I	O
have	O
shown	O
that	O
varicella	O
-	O
zoster	O
virus	O
(	O
VZV	O
)	O
envelope	O
glycoproteins	O
gpI	S-Protein
,	O
gpII	S-Protein
,	O
and	O
gpIII	S-Protein
can	O
be	O
labeled	O
with	O
[	O
35S	O
]	O
sulfate	O
.	O

The	O
predominant	O
VZV	O
glycoprotein	O
,	O
gpI	S-Protein
,	O
was	O
shown	O
to	O
be	O
sulfated	O
on	O
asparagine	O
-	O
linked	O
glycans	O
and	O
on	O
tyrosine	O
.	O

This	O
is	O
the	O
first	O
report	O
of	O
tyrosine	O
sulfation	O
of	O
a	O
viral	O
envelope	O
glycoprotein	O
.	O

Examination	O
of	O
the	O
predicted	O
amino	O
acid	O
sequences	O
of	O
gpI	S-Protein
from	O
the	O
Dumas	O
and	O
CP	O
-	O
5262	O
VZV	O
strains	O
revealed	O
the	O
presence	O
of	O
a	O
single	O
consensus	O
sequence	O
for	O
tyrosine	O
sulfation	O
of	O
tyr88	O
:	O
IWPRNDYDGFLEN	O
.	O

Consensus	O
sequences	O
are	O
also	O
present	O
in	O
the	O
homologues	O
of	O
gpI	S-Protein
in	O
herpes	O
simplex	O
type	O
1	O
,	O
herpes	O
simplex	O
type	O
2	O
,	O
and	O
pseudorabies	O
virus	O
,	O
suggesting	O
that	O
tyrosine	O
sulfation	O
may	O
be	O
a	O
general	O
post	O
-	O
translational	O
modification	O
of	O
the	O
neurotropic	O
alphaherpesviruses	O
.	O

Posttranslational	O
regulation	O
of	O
nitrogenase	O
activity	O
by	O
anaerobiosis	O
and	O
ammonium	O
in	O
Azospirillum	O
brasilense	O
.	O

In	O
the	O
microaerophilic	O
diazotroph	O
Azospirillum	O
brasilense	O
,	O
the	O
addition	O
of	O
fixed	O
nitrogen	O
or	O
a	O
shift	O
to	O
anaerobic	O
conditions	O
leads	O
to	O
a	O
rapid	O
loss	O
of	O
nitrogenase	O
activity	O
due	O
to	O
ADP	O
-	O
ribosylation	O
of	O
dinitrogenase	B-Protein
reductase	E-Protein
.	O

The	O
product	O
of	O
draT	S-Protein
(	O
DRAT	S-Protein
)	O
is	O
shown	O
to	O
be	O
necessary	O
for	O
this	O
modification	O
,	O
and	O
the	O
product	O
of	O
draG	S-Protein
(	O
DRAG	S-Protein
)	O
is	O
shown	O
to	O
be	O
necessary	O
for	O
the	O
removal	O
of	O
the	O
modification	O
upon	O
removal	O
of	O
the	O
stimulus	O
.	O

DRAG	S-Protein
and	O
DRAT	S-Protein
are	O
themselves	O
subject	O
to	O
posttranslational	O
regulation	O
,	O
and	O
this	O
report	O
identifies	O
features	O
of	O
that	O
regulation	O
.	O

We	O
demonstrate	O
that	O
the	O
activation	O
of	O
DRAT	S-Protein
in	O
response	O
to	O
an	O
anaerobic	O
shift	O
is	O
transient	O
but	O
that	O
the	O
duration	O
of	O
DRAT	S-Protein
activation	O
in	O
response	O
to	O
added	O
NH4	O
+	O
varies	O
with	O
the	O
NH4	O
+	O
concentration	O
.	O

In	O
contrast	O
,	O
DRAG	S-Protein
appears	O
to	O
be	O
continuously	O
active	O
under	O
conditions	O
favoring	O
nitrogen	O
fixation	O
.	O

Thus	O
,	O
the	O
activities	O
of	O
DRAG	S-Protein
and	O
DRAT	S-Protein
are	O
not	O
always	O
coordinately	O
regulated	O
.	O

Finally	O
,	O
our	O
experiments	O
suggest	O
the	O
existence	O
of	O
a	O
temporary	O
period	O
of	O
futile	O
cycling	O
during	O
which	O
DRAT	S-Protein
and	O
DRAG	S-Protein
are	O
simultaneously	O
adding	O
and	O
removing	O
ADP	O
-	O
ribose	O
from	O
dinitrogenase	B-Protein
reductase	E-Protein
,	O
immediately	O
following	O
the	O
addition	O
of	O
a	O
negative	O
stimulus	O
.	O

The	O
mevalonate	O
pathway	O
:	O
importance	O
in	O
mesangial	O
cell	O
biology	O
and	O
glomerular	O
disease	O
.	O

Products	O
of	O
intracellular	O
mevalonate	O
metabolism	O
are	O
critical	O
for	O
the	O
growth	O
and	O
proliferation	O
of	O
eukaryotic	O
cells	O
.	O

These	O
products	O
include	O
cholesterol	O
and	O
several	O
nonsterol	O
isoprenoids	O
.	O

The	O
isoprenoid	O
farnesyl	O
is	O
a	O
particularly	O
important	O
intermediate	O
in	O
the	O
mevalonate	O
pathway	O
.	O

Farnesyl	O
can	O
be	O
used	O
to	O
synthesize	O
cholesterol	O
and	O
can	O
also	O
bind	O
covalently	O
to	O
several	O
low	O
molecular	O
mass	O
GTP	O
-	O
binding	O
proteins	O
such	O
as	O
p21	B-Protein
ras	E-Protein
.	O

Farnesylated	O
p21	B-Protein
ras	E-Protein
may	O
be	O
critical	O
for	O
mitogenic	O
signalling	O
stimulated	O
by	O
growth	O
factors	O
such	O
as	O
platelet	O
-	O
derived	O
growth	O
factor	O
.	O

Inhibitors	O
of	O
the	O
enzyme	O
3	B-Protein
-	I-Protein
hydroxy	I-Protein
-	I-Protein
3	I-Protein
-	I-Protein
methylglutaryl	I-Protein
coenzyme	I-Protein
A	I-Protein
reductase	E-Protein
,	O
such	O
as	O
lovastatin	O
and	O
compactin	O
,	O
block	O
the	O
production	O
of	O
mevalonate	O
and	O
its	O
metabolites	O
.	O

These	O
agents	O
have	O
been	O
shown	O
to	O
inhibit	O
proliferation	O
of	O
many	O
cell	O
types	O
.	O

Recently	O
we	O
demonstrated	O
that	O
lovastatin	O
inhibited	O
proliferation	O
of	O
cultured	O
glomerular	O
mesangial	O
cells	O
.	O

Lovastatin	O
inhibition	O
was	O
overcome	O
by	O
the	O
simultaneous	O
addition	O
of	O
either	O
mevalonate	O
or	O
farnesol	O
,	O
but	O
not	O
by	O
exogenous	O
low	O
density	O
lipoprotein	O
cholesterol	O
.	O

These	O
results	O
suggested	O
that	O
farnesyl	O
is	O
critical	O
for	O
mesangial	O
cell	O
proliferation	O
.	O

In	O
several	O
experimental	O
models	O
of	O
renal	O
disease	O
,	O
chronic	O
lovastatin	O
administration	O
reduced	O
the	O
extent	O
of	O
glomerular	O
injury	O
.	O

The	O
beneficial	O
effects	O
of	O
lovastatin	O
have	O
been	O
attributed	O
to	O
lowering	O
of	O
circulating	O
lipid	O
and	O
lipoprotein	O
levels	O
.	O

In	O
view	O
of	O
recent	O
data	O
,	O
however	O
,	O
it	O
is	O
possible	O
that	O
lovastatin	O
may	O
act	O
to	O
reduce	O
glomerular	O
injury	O
,	O
at	O
least	O
in	O
part	O
,	O
through	O
a	O
direct	O
action	O
on	O
mesangial	O
cell	O
proliferation	O
.	O

Use	O
of	O
photoactivatable	O
peptide	O
substrates	O
of	O
Saccharomyces	O
cerevisiae	O
myristoyl	B-Protein
-	I-Protein
CoA	I-Protein
:	I-Protein
protein	I-Protein
N	I-Protein
-	I-Protein
myristoyltransferase	E-Protein
(	O
Nmt1p	S-Protein
)	O
to	O
characterize	O
a	O
myristoyl	O
-	O
CoA	O
-	O
Nmt1p	S-Protein
-	O
peptide	O
ternary	O
complex	O
and	O
to	O
provide	O
evidence	O
for	O
an	O
ordered	O
reaction	O
mechanism	O
.	O

Nmt1p	S-Protein
(	O
EC	O
2	O
.	O
3	O
.	O
1	O
.	O
97	O
)	O
catalyzes	O
the	O
transfer	O
of	O
myristate	O
(	O
C14	O
:	O
0	O
)	O
from	O
coenzyme	O
A	O
to	O
the	O
N	O
-	O
terminal	O
glycine	O
residue	O
of	O
a	O
variety	O
of	O
eukaryotic	O
cellular	O
and	O
viral	O
proteins	O
.	O

Our	O
recent	O
studies	O
of	O
the	O
455	O
-	O
amino	O
acid	O
Saccharomyces	O
cerevisiae	O
acyltransferase	O
(	O
Nmt1p	S-Protein
)	O
suggested	O
that	O
its	O
mechanism	O
of	O
catalysis	O
is	O
ordered	O
Bi	O
Bi	O
with	O
myristoyl	O
-	O
CoA	O
binding	O
occurring	O
prior	O
to	O
binding	O
of	O
peptide	O
and	O
release	O
of	O
CoA	O
occurring	O
prior	O
to	O
release	O
of	O
the	O
myristoyl	O
-	O
peptide	O
.	O

The	O
interaction	O
between	O
enzyme	O
and	O
peptide	O
has	O
now	O
been	O
examined	O
in	O
greater	O
detail	O
by	O
using	O
photoactivatable	O
octapeptide	O
substrates	O
containing	O
125I	O
-	O
labeled	O
azidosalicyclic	O
acid	O
attached	O
via	O
an	O
amide	O
bond	O
to	O
the	O
gamma	O
-	O
amino	O
group	O
of	O
a	O
diaminobutyrate	O
residue	O
located	O
at	O
position	O
2	O
or	O
the	O
epsilon	O
-	O
amino	O
group	O
of	O
a	O
lysine	O
residue	O
located	O
at	O
position	O
8	O
.	O

The	O
photopeptides	O
can	O
be	O
specifically	O
crosslinked	O
to	O
chymotryptic	O
fragments	O
of	O
Nmt1p	S-Protein
in	O
the	O
presence	O
but	O
not	O
in	O
the	O
absence	O
of	O
a	O
nonhydrolyzable	O
myristoyl	O
-	O
CoA	O
analog	O
,	O
S	O
-	O
(	O
2	O
-	O
oxo	O
)	O
pentadecyl	O
-	O
CoA	O
.	O

Labeling	O
of	O
the	O
chymotryptic	O
fragments	O
is	O
markedly	O
reduced	O
when	O
GLYASKLS	O
,	O
a	O
high	O
-	O
affinity	O
substrate	O
derived	O
from	O
residues	O
2	O
-	O
9	O
of	O
S	O
.	O
cerevisiae	O
ADP	B-Protein
-	I-Protein
ribosylation	I-Protein
factor	I-Protein
2	E-Protein
,	O
or	O
ALYASKLS	O
,	O
a	O
competitive	O
inhibitor	O
(	O
for	O
peptide	O
)	O
,	O
is	O
added	O
with	O
the	O
iodinated	O
photopeptide	O
.	O

These	O
findings	O
suggest	O
that	O
peptide	O
affinity	O
for	O
the	O
acyl	O
-	O
CoA	O
-	O
Nmt1p	S-Protein
binary	O
complex	O
is	O
much	O
greater	O
than	O
it	O
is	O
for	O
apoNmt1p	S-Protein
,	O
consistent	O
with	O
the	O
ordered	O
Bi	O
Bi	O
mechanism	O
ascribed	O
to	O
Nmt1p	S-Protein
.	O

Finally	O
,	O
automated	O
sequential	O
Edman	O
degradation	O
of	O
these	O
chymotryptic	O
fragments	O
suggests	O
that	O
the	O
peptide	O
binding	O
domain	O
of	O
Nmt1p	S-Protein
may	O
be	O
composed	O
of	O
elements	O
from	O
two	O
protease	O
-	O
resistant	O
domains	O
,	O
Arg42	O
-	O
Try219	O
and	O
Thr220	O
-	O
Leu455	O
.	O

Prenyl	O
modification	O
of	O
guanine	B-Protein
nucleotide	I-Protein
regulatory	I-Protein
protein	I-Protein
gamma	I-Protein
2	E-Protein
subunits	O
is	O
not	O
required	O
for	O
interaction	O
with	O
the	O
transducin	O
alpha	O
subunit	O
or	O
rhodopsin	S-Protein
.	O

Guanine	O
nucleotide	O
-	O
binding	O
regulatory	O
protein	O
(	O
G	O
protein	O
)	O
beta	O
gamma	O
dimers	O
that	O
were	O
active	O
in	O
reconstitution	O
assays	O
were	O
produced	O
in	O
insect	O
cells	O
using	O
the	O
baculovirus	O
/	O
Sf9	O
insect	O
cell	O
expression	O
system	O
.	O

Sf9	O
cells	O
were	O
infected	O
either	O
singly	O
or	O
in	O
combination	O
with	O
recombinant	O
baculoviruses	O
containing	O
a	O
human	O
G	B-Protein
-	I-Protein
protein	I-Protein
beta	I-Protein
1	E-Protein
gene	O
or	O
a	O
bovine	O
G	B-Protein
-	I-Protein
protein	I-Protein
gamma	I-Protein
2	E-Protein
gene	O
.	O

It	O
was	O
possible	O
to	O
express	O
the	O
beta	B-Protein
1	E-Protein
and	O
gamma	B-Protein
2	E-Protein
gene	O
products	O
independently	O
of	O
each	O
other	O
in	O
this	O
system	O
,	O
as	O
determined	O
by	O
using	O
immunological	O
and	O
metabolic	O
labeling	O
techniques	O
.	O

Further	O
,	O
the	O
ability	O
of	O
recombinant	O
beta	O
and	O
/	O
or	O
gamma	O
chains	O
to	O
function	O
in	O
defined	O
biochemical	O
assays	O
of	O
beta	O
gamma	O
activity	O
was	O
assessed	O
for	O
membrane	O
extracts	O
and	O
supernatant	O
fractions	O
from	O
infected	O
Sf9	O
cells	O
.	O

Extracts	O
of	O
cells	O
expressing	O
beta	O
or	O
gamma	O
chain	O
alone	O
were	O
inactive	O
in	O
these	O
assays	O
,	O
whereas	O
those	O
from	O
cells	O
coinfected	O
with	O
beta	B-Protein
1	E-Protein
and	O
gamma	B-Protein
2	E-Protein
did	O
display	O
activity	O
.	O

These	O
assays	O
were	O
used	O
to	O
identify	O
recombinant	O
beta	O
gamma	O
dimer	O
migration	O
during	O
chromatographic	O
purification	O
,	O
and	O
the	O
recombinant	O
dimers	O
were	O
purified	O
to	O
near	O
homogeneity	O
.	O

Both	O
the	O
membrane	O
-	O
associated	O
and	O
soluble	O
beta	O
gamma	O
dimers	O
facilitated	O
rhodopsin	S-Protein
-	O
catalyzed	O
guanosine	O
5	O
'	O
-	O
[	O
gamma	O
-	O
thio	O
]	O
triphosphate	O
binding	O
to	O
Gt	O
alpha	O
,	O
the	O
GTP	O
-	O
binding	O
subunit	O
of	O
the	O
retinal	O
G	O
protein	O
transducin	O
(	O
K0	O
.	O
5	O
of	O
13	O
+	O
/	O
-	O
2	O
and	O
36	O
+	O
/	O
-	O
5	O
nM	O
,	O
respectively	O
)	O
.	O

Both	O
recombinant	O
beta	O
gamma	O
dimers	O
also	O
facilitated	O
the	O
pertussis	O
toxin	O
-	O
catalyzed	O
ADP	O
-	O
ribosylation	O
of	O
Gt	O
alpha	O
with	O
equal	O
potency	O
(	O
K0	O
.	O
5	O
of	O
9	O
+	O
/	O
-	O
1	O
and	O
10	O
+	O
/	O
-	O
3	O
nM	O
for	O
membrane	O
and	O
soluble	O
dimers	O
,	O
respectively	O
)	O
.	O

[	O
3H	O
]	O
Mevalonolactone	O
labeling	O
showed	O
that	O
the	O
gamma	O
2	O
subunits	O
of	O
membrane	O
-	O
associated	O
beta	O
gamma	O
dimers	O
incorporated	O
radiolabel	O
,	O
whereas	O
in	O
the	O
soluble	O
form	O
they	O
did	O
not	O
.	O

Thus	O
,	O
prenyl	O
modification	O
of	O
gamma	B-Protein
2	E-Protein
directs	O
the	O
membrane	O
association	O
of	O
the	O
beta	B-Protein
1	I-Protein
gamma	I-Protein
2	E-Protein
dimer	O
and	O
increases	O
its	O
apparent	O
affinity	O
for	O
receptor	O
,	O
but	O
it	O
is	O
not	O
required	O
for	O
the	O
functional	O
interaction	O
(	O
s	O
)	O
of	O
the	O
dimer	O
.	O

The	O
role	O
of	O
G	O
protein	O
methylation	O
in	O
the	O
function	O
of	O
a	O
geranylgeranylated	O
beta	O
gamma	O
isoform	O
.	O

The	O
gamma	O
subunit	O
of	O
heterotrimeric	O
G	O
proteins	O
is	O
isoprenylated	O
and	O
methylated	O
on	O
its	O
carboxyl	O
terminal	O
cysteine	O
residue	O
.	O

While	O
retinal	O
transducin	O
is	O
farnesylated	O
,	O
all	O
other	O
gamma	O
subunits	O
are	O
modified	O
by	O
geranylgeranylation	O
.	O

An	O
immobilized	O
form	O
of	O
pig	O
liver	O
esterase	O
(	O
iPLE	O
)	O
is	O
able	O
to	O
hydrolyze	O
the	O
methyl	O
ester	O
of	O
a	O
geranylgeranylated	O
beta	O
gamma	O
isoform	O
(	O
beta	B-Protein
1	E-Protein
gamma	B-Protein
2	E-Protein
)	O
.	O

Since	O
methylation	O
is	O
the	O
only	O
reversible	O
reaction	O
in	O
the	O
isoprenylation	O
pathway	O
,	O
it	O
could	O
be	O
a	O
site	O
of	O
regulation	O
of	O
G	O
protein	O
activity	O
.	O

With	O
both	O
the	O
methylated	O
and	O
demethylated	O
beta	B-Protein
1	E-Protein
gamma	B-Protein
2	E-Protein
now	O
available	O
,	O
the	O
role	O
of	O
methylation	O
for	O
a	O
geranylgeranylated	O
heterotrimeric	O
G	O
protein	O
may	O
be	O
addressed	O
.	O

Here	O
,	O
it	O
is	O
reported	O
that	O
methylation	O
has	O
no	O
effect	O
on	O
the	O
ability	O
of	O
beta	O
gamma	O
to	O
interact	O
with	O
an	O
alpha	O
subunit	O
,	O
as	O
probed	O
by	O
ADP	O
-	O
ribosylation	O
studies	O
with	O
pertussis	O
toxin	O
,	O
and	O
has	O
a	O
small	O
effect	O
(	O
less	O
than	O
2	O
-	O
fold	O
)	O
on	O
the	O
ability	O
of	O
geranylgeranylated	O
beta	O
gamma	O
to	O
activate	O
phosphatidylinositol	O
-	O
specific	O
phospholipase	O
C	O
(	O
PIPLC	O
)	O
and	O
phosphoinositide	O
3	O
kinase	O
(	O
PI3K	O
)	O
.	O

In	O
binding	O
studies	O
,	O
demethylation	O
only	O
slightly	O
decreased	O
the	O
ability	O
of	O
beta	B-Protein
1	E-Protein
gamma	B-Protein
2	E-Protein
to	O
adhere	O
to	O
azolectin	O
vesicles	O
.	O

Therefore	O
,	O
methylation	O
of	O
heterotrimeric	O
G	O
proteins	O
appears	O
to	O
have	O
only	O
a	O
minor	O
effect	O
in	O
signal	O
transduction	O
processes	O
which	O
can	O
be	O
correlated	O
to	O
a	O
decrease	O
in	O
hydrophobicity	O
of	O
the	O
beta	O
gamma	O
subunit	O
.	O

Purification	O
of	O
a	O
protein	O
palmitoyltransferase	O
that	O
acts	O
on	O
H	B-Protein
-	I-Protein
Ras	E-Protein
protein	O
and	O
on	O
a	O
C	O
-	O
terminal	O
N	B-Protein
-	I-Protein
Ras	E-Protein
peptide	O
.	O

Mammalian	O
H	B-Protein
-	I-Protein
Ras	E-Protein
and	O
N	B-Protein
-	I-Protein
Ras	E-Protein
are	O
GTP	O
-	O
binding	O
proteins	O
that	O
must	O
be	O
post	O
-	O
translationally	O
lipidated	O
to	O
function	O
as	O
molecular	O
switches	O
in	O
signal	O
transduction	O
cascades	O
controlling	O
cell	O
growth	O
and	O
differentiation	O
.	O

These	O
proteins	O
contain	O
a	O
C	O
-	O
terminal	O
farnesyl	O
-	O
cysteine	O
alpha	O
-	O
methyl	O
ester	O
and	O
palmitoyl	O
groups	O
attached	O
to	O
nearby	O
cysteines	O
.	O

Data	O
is	O
presented	O
showing	O
that	O
rat	O
liver	O
microsomes	O
contain	O
an	O
enzyme	O
that	O
transfers	O
the	O
palmitoyl	O
group	O
from	O
palmitoyl	O
-	O
coenzyme	O
A	O
to	O
cysteine	O
residues	O
of	O
H	B-Protein
-	I-Protein
Ras	E-Protein
protein	O
and	O
of	O
a	O
synthetic	O
peptide	O
having	O
the	O
structure	O
of	O
the	O
C	O
terminus	O
of	O
N	B-Protein
-	I-Protein
Ras	E-Protein
.	O

This	O
protein	O
palmitoyltransferase	O
(	O
PPT	O
)	O
was	O
solubilized	O
from	O
membranes	O
and	O
purified	O
10	O
,	O
500	O
-	O
fold	O
to	O
apparent	O
homogeneity	O
with	O
an	O
overall	O
yield	O
of	O
10	O
%	O
.	O

On	O
an	O
SDS	O
gel	O
,	O
PPT	O
appears	O
as	O
two	O
proteins	O
of	O
molecular	O
masses	O
of	O
approximately	O
30	O
and	O
approximately	O
33	O
kDa	O
.	O

If	O
the	O
palmitoylation	O
sites	O
of	O
the	O
N	B-Protein
-	I-Protein
Ras	E-Protein
peptide	O
(	O
the	O
non	O
-	O
farnesylated	O
cysteine	O
)	O
or	O
H	B-Protein
-	I-Protein
Ras	E-Protein
protein	O
(	O
cysteines	O
181	O
and	O
184	O
)	O
are	O
changed	O
to	O
serine	O
,	O
palmitoylation	O
by	O
PPT	O
does	O
not	O
occur	O
.	O

Non	O
-	O
farnesylated	O
H	B-Protein
-	I-Protein
Ras	E-Protein
produced	O
in	O
bacteria	O
as	O
well	O
as	O
in	O
vitro	O
farnesylated	O
bacterial	O
H	B-Protein
-	I-Protein
Ras	E-Protein
are	O
not	O
substrates	O
for	O
PPT	O
nor	O
is	O
the	O
non	O
-	O
farnesylated	O
,	O
methylated	O
N	B-Protein
-	I-Protein
Ras	E-Protein
peptide	O
.	O

These	O
results	O
suggest	O
,	O
but	O
do	O
not	O
prove	O
,	O
that	O
farnesylation	O
and	O
possibly	O
C	O
-	O
terminal	O
methylation	O
are	O
prerequisites	O
for	O
Ras	O
palmitoylation	O
.	O

PPT	O
shows	O
a	O
large	O
preference	O
for	O
palmitoyl	O
-	O
coenzyme	O
A	O
over	O
myristoyl	O
-	O
coenzyme	O
as	O
the	O
acyl	O
donor	O
.	O

Values	O
of	O
Km	O
for	O
palmitoyl	O
-	O
CoA	O
and	O
H	B-Protein
-	I-Protein
Ras	E-Protein
are	O
4	O
.	O
3	O
+	O
/	O
-	O
1	O
.	O
2	O
and	O
0	O
.	O
8	O
+	O
/	O
-	O
0	O
.	O
3	O
microM	O
,	O
respectively	O
.	O

PPT	O
is	O
the	O
first	O
protein	O
palmitoyltransferase	O
to	O
be	O
purified	O
,	O
and	O
the	O
availability	O
of	O
pure	O
enzyme	O
should	O
contribute	O
to	O
our	O
understanding	O
of	O
the	O
function	O
and	O
regulation	O
of	O
Ras	O
palmitoylation	O
in	O
cells	O
.	O

Prenylated	O
isoforms	O
of	O
yeast	O
casein	O
kinase	O
I	O
,	O
including	O
the	O
novel	O
Yck3p	S-Protein
,	O
suppress	O
the	O
gcs1	S-Protein
blockage	O
of	O
cell	O
proliferation	O
from	O
stationary	O
phase	O
.	O

The	O
GCS1	S-Protein
gene	O
of	O
the	O
budding	O
yeast	O
Saccharomyces	O
cerevisiae	O
mediate	O
the	O
resumption	O
of	O
cell	O
proliferation	O
from	O
the	O
starved	O
,	O
stationary	O
-	O
phase	O
state	O
.	O

Here	O
we	O
identify	O
yeast	O
genes	O
that	O
,	O
in	O
increased	O
dosages	O
,	O
overcome	O
the	O
growth	O
defect	O
of	O
gcs1	S-Protein
delta	O
mutant	O
cells	O
.	O

Among	O
these	O
are	O
YCK1	S-Protein
(	O
CK12	S-Protein
)	O
and	O
YCK2	S-Protein
(	O
CKI1	S-Protein
)	O
,	O
encoding	O
membrane	O
-	O
associated	O
casein	O
kinase	O
I	O
,	O
and	O
YCK3	S-Protein
,	O
encoding	O
a	O
novel	O
casein	O
kinase	O
I	O
isoform	O
.	O

Some	O
Yck3p	S-Protein
gene	O
product	O
was	O
found	O
associated	O
with	O
the	O
plasma	O
membrane	O
,	O
like	O
Yck1p	S-Protein
and	O
Yck2p	S-Protein
,	O
but	O
most	O
confractionated	O
with	O
the	O
nucleus	O
,	O
like	O
another	O
yeast	O
casein	O
kinase	O
I	O
isoform	O
,	O
Hrr25p	S-Protein
.	O

Genetic	O
studies	O
showed	O
that	O
YCK3	S-Protein
and	O
HRR25	S-Protein
constitute	O
an	O
essential	O
gene	O
family	O
and	O
that	O
Yck3p	S-Protein
can	O
weakly	O
substitute	O
for	O
Yck1p	S-Protein
-	O
Yck2p	S-Protein
.	O

For	O
gcs1	S-Protein
delta	O
suppression	O
,	O
both	O
a	O
protein	O
kinase	O
domain	O
and	O
a	O
C	O
-	O
terminal	O
prenylation	O
motif	O
were	O
shown	O
to	O
be	O
necessary	O
.	O

An	O
impairment	O
in	O
endocytosis	O
was	O
found	O
for	O
gcs1	S-Protein
delta	O
mutant	O
cells	O
,	O
which	O
was	O
alleviated	O
by	O
an	O
increased	O
YCK2	S-Protein
gene	O
dosage	O
.	O

The	O
ability	O
of	O
an	O
increased	O
casein	O
kinase	O
I	O
gene	O
dosage	O
to	O
suppress	O
the	O
effects	O
caused	O
by	O
the	O
absence	O
of	O
Gcs1p	S-Protein
suggests	O
that	O
Gcs1p	S-Protein
and	O
Yck1p	S-Protein
-	O
Yck2p	S-Protein
affect	O
parallel	O
pathways	O
.	O

Protection	O
against	O
Fas	S-Protein
/	O
APO	B-Protein
-	I-Protein
1	E-Protein
-	O
and	O
tumor	O
necrosis	O
factor	O
-	O
mediated	O
cell	O
death	O
by	O
a	O
novel	O
protein	O
,	O
sentrin	S-Protein
.	O

Fas	S-Protein
/	O
APO	B-Protein
-	I-Protein
1	E-Protein
and	O
TNF	B-Protein
receptor	I-Protein
1	E-Protein
share	O
a	O
common	O
signaling	O
motif	O
in	O
their	O
cytoplasmic	O
tail	O
called	O
the	O
"	O
death	O
domain	O
.	O
"	O
Using	O
the	O
death	O
domain	O
as	O
bait	O
in	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
,	O
several	O
death	O
domain	O
-	O
containing	O
proteins	O
that	O
participate	O
in	O
cell	O
death	O
signaling	O
have	O
been	O
identified	O
.	O

Here	O
we	O
report	O
the	O
isolation	O
of	O
a	O
novel	O
protein	O
,	O
sentrin	S-Protein
,	O
which	O
interacts	O
with	O
Fas	S-Protein
/	O
APO	B-Protein
-	I-Protein
1	E-Protein
and	O
TNF	B-Protein
receptor	I-Protein
1	E-Protein
but	O
not	O
with	O
FADD	S-Protein
/	O
MORT1	S-Protein
or	O
CD40	S-Protein
.	O

Two	O
-	O
hybrid	O
interaction	O
assays	O
reveal	O
that	O
sentrin	S-Protein
associates	O
only	O
with	O
the	O
signal	O
-	O
competent	O
forms	O
of	O
Fas	S-Protein
/	O
APO	B-Protein
-	I-Protein
1	E-Protein
or	O
TNF	B-Protein
receptor	I-Protein
1	E-Protein
death	O
domains	O
.	O

Sentrin	S-Protein
is	O
a	O
novel	O
protein	O
of	O
101	O
amino	O
acids	O
with	O
homology	O
to	O
ubiquitin	S-Protein
,	O
Nedd8	S-Protein
,	O
and	O
a	O
Saccharomyces	O
cerevisiae	O
protein	O
,	O
Smt3	S-Protein
.	O

When	O
overexpressed	O
,	O
sentrin	S-Protein
provides	O
protection	O
against	O
both	O
anti	O
-	O
Fas	S-Protein
/	O
APO	B-Protein
-	I-Protein
1	E-Protein
and	O
TNF	O
-	O
induced	O
cell	O
death	O
.	O

Effect	O
of	O
insulin	S-Protein
on	O
farnesyltransferase	O
activity	O
in	O
3T3	O
-	O
L1	O
adipocytes	O
.	O

Activation	O
of	O
p21	B-Protein
(	I-Protein
ras	I-Protein
)	E-Protein
by	O
GTP	O
loading	O
is	O
a	O
critical	O
step	O
in	O
a	O
cascade	O
of	O
intracellular	O
insulin	S-Protein
signaling	O
.	O

Farnesylation	O
of	O
p21	B-Protein
(	I-Protein
ras	I-Protein
)	E-Protein
protein	O
is	O
an	O
obligatory	O
event	O
that	O
facilitates	O
Ras	O
migration	O
to	O
the	O
plasma	O
membrane	O
and	O
subsequent	O
activation	O
.	O

Farnesyltransferase	O
(	O
FTase	O
)	O
is	O
a	O
ubiquitous	O
enzyme	O
that	O
catalyzes	O
the	O
lipid	O
modification	O
of	O
p21	B-Protein
(	I-Protein
ras	I-Protein
)	E-Protein
by	O
the	O
addition	O
of	O
farnesyl	O
to	O
the	O
C	O
-	O
terminal	O
"	O
CAAX	O
"	O
motif	O
.	O

In	O
vitro	O
and	O
in	O
vivo	O
FTase	O
activities	O
were	O
studied	O
in	O
3T3	O
-	O
L1	O
adipocytes	O
in	O
response	O
to	O
insulin	S-Protein
challenge	O
.	O

Insulin	S-Protein
exerted	O
a	O
biphasic	O
stimulatory	O
effect	O
on	O
FTase	O
activity	O
measured	O
in	O
vitro	O
with	O
a	O
31	O
%	O
increase	O
at	O
5	O
min	O
and	O
a	O
130	O
%	O
increase	O
at	O
60	O
min	O
.	O

Insulin	S-Protein
-	O
stimulated	O
farnesylation	O
of	O
p21	B-Protein
(	I-Protein
ras	I-Protein
)	E-Protein
pools	O
in	O
vivo	O
correlated	O
with	O
FTase	O
activity	O
seen	O
in	O
vitro	O
by	O
displaying	O
an	O
increase	O
in	O
farnesylated	O
p21	B-Protein
(	I-Protein
ras	I-Protein
)	E-Protein
from	O
40	O
%	O
of	O
total	O
cellular	O
Ras	O
in	O
control	O
cells	O
to	O
63	O
%	O
by	O
5	O
min	O
and	O
80	O
%	O
by	O
60	O
min	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
insulin	S-Protein
-	O
treated	O
cells	O
.	O

Insulin	S-Protein
challenge	O
of	O
3T3	O
-	O
L1	O
adipocytes	O
increased	O
incorporation	O
of	O
tritiated	O
mevalonic	O
acid	O
in	O
p21	B-Protein
(	I-Protein
ras	I-Protein
)	E-Protein
in	O
a	O
dose	O
-	O
dependent	O
manner	O
and	O
stimulated	O
a	O
2	O
-	O
fold	O
increase	O
in	O
phosphorylation	O
of	O
the	O
alpha	O
-	O
subunit	O
of	O
FTase	O
at	O
5	O
min	O
and	O
a	O
4	O
-	O
fold	O
increase	O
at	O
60	O
min	O
.	O

Caspase	B-Protein
-	I-Protein
2	E-Protein
(	O
Nedd	B-Protein
-	I-Protein
2	E-Protein
)	O
processing	O
and	O
death	O
of	O
trophic	O
factor	O
-	O
deprived	O
PC12	O
cells	O
and	O
sympathetic	O
neurons	O
occur	O
independently	O
of	O
caspase	B-Protein
-	I-Protein
3	E-Protein
(	O
CPP32	S-Protein
)	O
-	O
like	O
activity	O
.	O

We	O
have	O
previously	O
shown	O
that	O
caspase	B-Protein
-	I-Protein
2	E-Protein
(	O
Nedd	B-Protein
-	I-Protein
2	E-Protein
)	O
is	O
required	O
for	O
apoptosis	O
induced	O
by	O
withdrawal	O
of	O
trophic	O
support	O
from	O
PC12	O
cells	O
and	O
sympathetic	O
neurons	O
.	O

Here	O
,	O
we	O
examine	O
the	O
relationship	O
of	O
caspase	B-Protein
-	I-Protein
2	E-Protein
processing	O
and	O
cell	O
death	O
to	O
induction	O
of	O
caspase	B-Protein
-	I-Protein
3	E-Protein
(	O
CPP32	S-Protein
)	O
-	O
like	O
activity	O
in	O
PC12	O
cells	O
.	O

Caspase	B-Protein
-	I-Protein
2	E-Protein
processing	O
,	O
at	O
a	O
site	O
tentatively	O
identified	O
as	O
D333	O
,	O
led	O
to	O
the	O
formation	O
of	O
an	O
N	O
-	O
terminal	O
37	O
kDa	O
product	O
.	O

This	O
processing	O
correlated	O
temporally	O
with	O
induction	O
of	O
caspase	B-Protein
-	I-Protein
3	E-Protein
-	O
like	O
activity	O
.	O

Agents	O
previously	O
shown	O
to	O
inhibit	O
caspase	B-Protein
-	I-Protein
3	E-Protein
-	O
like	O
activation	O
,	O
such	O
as	O
bcl	B-Protein
-	I-Protein
2	E-Protein
and	O
the	O
Cdk	O
inhibitor	O
flavopiridol	O
,	O
also	O
acted	O
upstream	O
of	O
caspase	B-Protein
-	I-Protein
2	E-Protein
processing	O
.	O

The	O
general	O
caspase	O
inhibitors	O
BAF	O
and	O
zVAD	O
-	O
FMK	O
inhibited	O
N	O
-	O
terminal	O
caspase	B-Protein
-	I-Protein
2	E-Protein
processing	O
.	O

In	O
contrast	O
,	O
the	O
more	O
selective	O
caspase	O
inhibitor	O
DEVD	O
-	O
FMK	O
inhibited	O
the	O
induction	O
of	O
caspase	B-Protein
-	I-Protein
3	E-Protein
-	O
like	O
activity	O
but	O
did	O
not	O
affect	O
caspase	B-Protein
-	I-Protein
2	E-Protein
processing	O
or	O
significantly	O
suppress	O
death	O
in	O
PC12	O
cells	O
or	O
sympathetic	O
neurons	O
.	O

This	O
indicates	O
that	O
caspase	B-Protein
-	I-Protein
3	E-Protein
-	O
like	O
activity	O
is	O
not	O
required	O
for	O
either	O
caspase	B-Protein
-	I-Protein
2	E-Protein
processing	O
or	O
apoptosis	O
in	O
this	O
paradigm	O
.	O

An	O
antisense	O
oligonucleotide	O
to	O
caspase	B-Protein
-	I-Protein
2	E-Protein
inhibited	O
cell	O
death	O
but	O
did	O
not	O
affect	O
caspase	B-Protein
-	I-Protein
3	E-Protein
-	O
like	O
activity	O
,	O
indicating	O
that	O
caspase	B-Protein
-	I-Protein
2	E-Protein
is	O
not	O
upstream	O
of	O
this	O
activity	O
and	O
that	O
activation	O
of	O
caspase	B-Protein
-	I-Protein
3	E-Protein
-	O
like	O
caspases	O
is	O
not	O
sufficient	O
for	O
death	O
.	O

Thus	O
,	O
in	O
our	O
paradigm	O
,	O
caspase	B-Protein
-	I-Protein
2	E-Protein
processing	O
and	O
caspase	B-Protein
-	I-Protein
3	E-Protein
-	O
like	O
activity	O
are	O
induced	O
independently	O
of	O
each	O
other	O
.	O

Moreover	O
,	O
although	O
death	O
requires	O
caspase	B-Protein
-	I-Protein
2	E-Protein
,	O
caspase	B-Protein
-	I-Protein
3	E-Protein
-	O
like	O
activity	O
is	O
neither	O
necessary	O
nor	O
sufficient	O
for	O
death	O
.	O
